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DESIGN, FABRICATION, AND VALIDATION OF 3D PRINTED, PATIENT-SPECIFIC 
COMPENSATORS FOR POSTMASTECTOMY RADIATION THERAPY 
Abstract 
Daniel Fowler Craft, B.S. 
Advisory Professor: Rebecca M. Howell, Ph.D. 
 
 The purpose of this study was to use 3D printed, patient-specific tissue compensators 
to overcome the 3D planning limitations for postmastectomy radiation therapy (PMRT). 
Tissue compensators can be used to reduce dose heterogeneity, hot and cold spots at field 
junctions, and treatment complexity, but are currently seldom used due to the difficulty in 
designing, fabricating, and validating them.  
 To produce compensators using 3D printing technology, suitable materials had to be 
found and characterized. Several materials were found to be promising, but previously 
unreported material uncertainties were also discovered that must be carefully controlled for 
in 3D printing studies. A new algorithm was also created to optimally design the 
compensator shape to conform the dose to the desired region, while maintaining acceptable 
geometric considerations for 3D printing. Patients’ dose distributions calculated using this 
algorithm were superior to dose distributions calculated in those same patients using more 
conventional matched field plans. To validate the idealized dose distributions, a new 
technique was developed to 3D print patient-specific, large scale radiotherapy phantoms with 
dosimeters throughout that can accurately reflect patients’ anatomy better than generalized 
phantoms. Six of these phantoms were created for a sample of patients with a range of body 
vi 
 
sizes. A sample of compensators was designed and printed for these novel phantoms, and 
radiation doses were measured and compared to planned dose distributions. Measured doses 
agreed well with planned doses. 
 This study demonstrates that 3D printed, patient-specific compensators can be used to 
simplify treatments, and improve dose distributions in PMRT patients relative to their 
conventional 3D plans. Additionally, the algorithm could be applied to calculate 
compensators for different treatment sites in the future, and the phantoms developed could be 
used to perform pseudo in vivo dosimetry measurements for a wide range of radiotherapy 
experiments. 
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Chapter 1: Introduction 
 Breast cancer is the most commonly diagnosed cancer in women in the United States, 
with an expected 266,120 newly diagnosed cases in 20181. Additionally, breast cancer is 
second only to lung cancer in cancer fatalities among women, with approximately 41,000 
estimated deaths in 2018. One out of eight women in the United States will be diagnosed 
with breast cancer in their lifetime1. For node-positive disease, the standard of treatment is 
surgical removal of the breast, followed by adjuvant radiation therapy, because this has been 
shown to increase the probability of survival, and decrease the risk of loco regional 
recurrence2-4.  
While postmastectomy radiation therapy (PMRT) has been shown in randomized trials to 
improve survival and recurrence outcomes5, it is technically difficult to deliver. The target 
region includes the chest wall around the surgical area as well as proximal lymph nodes 
(IMC). This is a potentially large area that varies in thickness and composition greatly, with 
ribs, fatty tissue, and muscle all in close proximity to each other. The patient’s skin surface is 
also likely uneven, with depressions and uneven scarring possible. Another concern is the 
relative proximity of important non-target organs, including the heart, lungs, and 
contralateral breast, which may all be within a few centimeters of the target. To account for 
these difficulties, most PMRT plans use matched tangent photon fields with additional 
electron fields for the IMC. While these fields are aligned and matched carefully, these 
PMRT plans still result in hot and cold spots at field junctions, are difficult to plan, and are 
difficult to set up and deliver6. While intensity modulated radiation therapy (IMRT) is 
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occasionally used for PMRT, it is also associated with higher lung, heart, spinal cord, and 
contralateral breast doses than conventional 3D plans7. 
 One option to simplify PMRT treatments is the use of electron therapy in conjunction 
with patient-specific tissue compensators. Electrons have a finite range in tissue, so are in 
some cases better suited to treating relatively superficial disease sites. When used with a 
tissue compensator the dose distribution from an electron beam can be kept quite conformal 
around the distal edge of the target area. Techniques to design patient-specific bolus were 
first published in the 1990s8, 9. Since then, patient-specific compensators have been used for 
PMRT10-12, as well as a variety of other disease sites including cancers of the head and 
neck13, 14, basal cell carcinoma15, melanoma16, soft tissue sarcomas17, and other types of 
treatment9, 18.  
Tissue compensators are not regularly used, despite the advantages they provide in 
treatment simplicity and improved dosimetry, due to a combination of inconvenience and 
inaccessibility. Compensators conventionally have been fabricated from wax molding and 
machine molding, processes that require specialized equipment, are time-consuming and 
labor-intensive, and in the case of wax molding are potentially prone to error19. Additionally, 
while several techniques have been published describing compensator design8, 13, 20, these 
compensator design algorithms are not included as part of most standard treatment planning 
systems (TPS).An additional limitation of these compensators is that they are all designed to 
fit on a patient’s surface, which requires non-irritating biocompatible materials and is 
potentially prone to daily set up uncertainty19. 
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One alternative to conventional fabrication is three dimensional (3D) printing technology. 
3D printers turn computer designed models into solid objects by depositing single layers of 
material down on top of each other. The two most common types of 3D printers are 
stereolithography (SLA) printers, which use lasers to cure resin in successive layers, and 
fused deposition modeling (FDM) printers, which melt and extrude plastic through a heated 
hot-end extruder to trace out each layer21. Layer resolutions can be as small as 15µm for SLA 
printers, but are generally limited to 100 µm for FDM printers. However, high quality FDM 
printers are much more accessible, and much less expensive (<$15,000) than comparably 
sized SLA printers, which can cost in excess of $100,000. There are some design limitations 
to what 3D printers can fabricate—for example, as each model grows there must be sufficient 
support under layers for the next layer to be deposited on, so extreme overhangs can be 
difficult to print—but generally they use less material than other manufacturing techniques, 
and can print more shapes with more accuracy and less human involvement. Perhaps most 
importantly, FDM printers are relatively simple to use, and can be used to fabricate devices 
entirely in-house. 
As 3D printers have become more widely available in recent years, interest in using them 
for external beam radiotherapy has increased. Within the last several years, Su et al.20 printed 
small electron boluses using an in-house design algorithm and an FDM printer, Ju et al.22 
printed and evaluated a proton range compensator using an SLA printer, Zou et al.23 printed a 
50% scale electron compensator for scalp therapy and a 50% scale proton compensator for 
prostate therapy, and Burleson et al.24 printed a small compensator to conform to the nose of 
an anthropomorphic phantom. All of these studies used rigid plastics for surface based 
devices, and 3D printers with small maximum print volumes (e.g., all print dimensions less 
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than 10 cm). The small maximum print volumes and use of rigid materials for surface based 
devices have thus far limited the use of 3D printed compensators to small treatment areas 
with rigid anatomy. Another use of 3D printers is the production of patient-specific phantoms 
based on patients’ medical images25, 26. Several groups have used 3D printing to make such 
phantoms, for a variety of specific applications27-32, but have also been relatively limited by 
using smaller-scale printers. 
The goal of this study was to use 3D printing technology to overcome limitations in 
current 3D treatment planning for PMRT. Specifically, we aimed to characterize 3D printing 
materials and processes, develop an algorithm to design 3D printable compensators which 
would be positioned at some distance from the patient’s skin surface, evaluate dosimetric 
qualities of compensator based plans, and validate compensator planning doses with 
measurements in 3D printed, patient-specific phantoms.  
Chapter 2 of this dissertation details the hypothesis, specific aims, and various 
projects to test each aim. Chapter 3 details our studies into 3D printing material properties. 
Chapter 4 describes our fabrication process for 3D printing patient-specific phantoms. 
Chapter 5 includes patient dose comparisons as well as phantom validation results. Chapter 6 
is a discussion of our results, and future directions of study. The appendices include 
supplemental patient data, recommendations on 3D printing settings and procedures, studies 
into patient-specific surface based compensators, and the code of the algorithm used and 
described in Chapter 5.  
5 
 
Chapter 2: Central Hypothesis and Specific Aims 
Central Hypothesis 
The central hypothesis of this dissertation is that 3D printed, patient-specific tissue 
compensators can reduce harmful dose inhomogeneity in PMRT patients relative to current 
standard of care tangent field plans, while maintaining adequate clinical target coverage. 
 
Specific Aim 1: Characterize 3D Printed Materials and Processes 
Aim: Evaluate and optimize 3D printing materials and processes to find suitable plastics for 
printing tissue equivalent compensators. 
Hypothesis: At least one commercially available material for 3D printing is suitable for use 
as a chest wall tissue compensator. 
Project 1.1: Print a range of materials, and analyze them for basic physical and 
radiological properties such as density, average CT number, print accuracy, etc. 
Project 1.2: Perform percent depth dose measurements for a full range of clinical 
electron and photon energies for any materials with suitable characteristics. 
Project 1.3: Determine clinical reliability of 3D printed materials by printing and 
observing several samples over the course of many weeks. 
Specific Aim 1 is fully addressed in Chapter 3: Characterization of 3D Printing Materials. 
 
Specific Aim 2: Phantom Development 
Aim: Design and fabricate a sample of patient-specific, whole body phantoms of PMRT 
patients. 
6 
 
Hypothesis: 3D printed phantoms that accurately reflect patient-specific anatomy can be 
produced reliably and inexpensively. 
Project 2.1: Design and print a selection of full body phantoms based on CT data 
from the PMRT patients analyzed in Aim 2. 
Project 2.2: Validate printed phantoms with their source CT data.  
Specific Aim 2 is fully addressed in Chapter 4: Phantom Development. 
 
Specific Aim 3: Demonstrate Clinical Feasibility 
Aim: Create a tool to design patient-specific compensators, and quantify dose distribution 
improvements in treatment planning studies relative to patients’ standard of care plans. 
Hypothesis: Treatment plans using compensators will satisfy clinical coverage requirements, 
while reducing dose inhomogeneity compared to standard treatment plans. 
Project 3.1: Develop an algorithm to automatically design patient-specific 
compensators that achieve adequate dose coverage. 
Project 3.2: For a sample of PMRT patients, apply the compensator design algorithm 
and calculate average dose characteristics. 
Project 3.3: Compare dose characteristics from project 3.2 with the dose distributions 
patients received from their standard of care treatment plans. 
Specific Aim 3 is fully addressed in Chapter 5: Design and Validation of Physical 
Compensators. 
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Specific Aim 4: Validate Compensators with Physical Phantoms 
Aim: Validate treatment planning dose distributions using the compensators from Aim 2 and 
the phantoms from Aim 3. 
Hypothesis: Measured dose distributions in patient-specific phantoms match expected dose 
distributions from treatment planning studies. 
Project 4.1: Apply the algorithm from Aim 2 to each of the phantoms fabricated in 
Aim 3 to design and print a compensator for each phantom. 
Project 4.2: Print a wedge compensator and use it to measure dose profiles in solid 
water. 
Project 4.3: Deliver compensator treatment plans to each phantom, and compare 
dose distributions measured with TLD and film with the planned dose distributions. 
Specific aim 4 is fully addressed in Chapter 5: Design and Validation of Physical 
Compensators. 
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Chapter 3: Characterization of 3D Printing Materials 
This chapter is based upon the following publication: 
D.F. Craft, S. F. Kry, P. Balter, M. Salehpour, W. Woodward, and R.M. Howell, “Material 
Matters: Analysis of Density Uncertainty in 3D Printing and its Consequences for Radiation 
Oncology,” Medical Physics. Volume 45, Issue 4, pages 1614-1621. 2018. © John Wiley and 
Sons, Inc. 
The permission for reuse of this material was obtained from the John Wiley and Sons, Inc. 
This chapter describes the results of Specific Aim 1: Evaluate and optimize 3D 
printing materials and processes to find suitable plastics for printing tissue equivalent 
compensators. 
I.   INTRODUCTION 
Within the last several years, 3D printing technology has become an increasingly 
utilized tool in the radiotherapy community. The ability to rapidly and accurately 
manufacture custom-designed objects has generated much interest in utilizing this technology 
to create patient-specific devices and custom in-house phantoms. 3D printers and their 
materials are relatively inexpensive and simple to operate, making specialized phantoms and 
patient-specific devices a possibility for a fraction of the cost of commercially available 
options. 
Several recent studies have reported clinical applications of 3D printed objects, 
including boluses for the head and neck area33-35, a patient-specific bolus for electron beam 
therapy36, and vaginal brachytherapy applicators37. Several studies have examined the 
9 
 
potential in the nonclinical setting for customized boluses24, 38, 39 and proton range 
compensators23, 40. Another active area of 3D printing research is in creating custom 
phantoms used for imaging30, 41, training25, 29, and various radiotherapy applications27, 42, 43.  
Despite the great interest in using 3D printed materials for radiologic applications, 
relatively little work has been done to fully characterize the radiologic properties of the 
materials used for printing. Cunha et al.44 evaluated PC-ISO for use in high dose rate 
brachytherapy applicators and found it to be sufficiently water-equivalent for their clinical 
workflow. Dancewicz et al.45 and Madamesila et al.31 both characterized materials at 
different infill percentages, attempting to match them with various anatomic regions. All of 
these studies examined single samples of each material or infill density. While this is an 
important reference point, there is inherent uncertainty in the 3D printing process that must 
also be accounted for. For example, many of these studies reported different mean 
Hounsfield Units (HUs) and physical densities of common materials, suggesting that 
different print jobs may, in fact, have different densities. Additionally, these studies have 
often failed to address the fact that, for many 3D printing materials, the HU-to-density 
relationship cannot be properly modeled by treatment planning systems (TPS) without 
overriding material properties24. These findings raise serious concerns about the consistency 
and radiologic suitability of 3D printed materials. 
In this chapter, we address these issues of consistency and radiologic suitability of 3D 
printed materials. Specifically, the objectives of our study were to [1] determine the variance 
in HU and density for objects printed with identical equipment and materials, [2] determine if 
HU varies over time based on storage environment, and [3] determine the clinical (i.e., 
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dosimetric) dose uncertainty as a function of material variation and how that relates to 
clinical use of 3D printed materials. 
II.   MATERIALS AND METHODS 
A. Material Variations 
We printed 10 27-cm3 cubes of each of four different materials: polylactic acid 
(PLA), acrylonitrile butadiene styrene (ABS), NinjaFlex, and Cheetah. All blocks were 
printed by the same Gigabot 3.0 3D printer (re3D, Houston, TX). We selected this printer 
because it is a relatively inexpensive (<$15,000), with a large print bed (60 cm × 60 cm × 54 
cm) suitable for printing both small and large objects.  All blocks of each type of material 
were printed from the same original material spool. A computer tomographic (CT) image 
was acquired of each block on a Philips Brilliance Big Bore (Philips Healthcare, Andover, 
MA) the day after printing, and the physical density of each block was measured using 
calipers and a precision balance. Figure 3.1 pictures representative examples of each material 
block. 
 
Figure 3.1: Pictures of 3D printed blocks of the four studied materials. From the left: PLA, 
NinjaFlex, ABS, and Cheetah. 
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Half of the blocks of each material were stored in an open box and the other half were 
stored in sealed bags containing desiccant. Every block was CT imaged once weekly for 5 
weeks. For each material and storage type, weekly HU drift trends were plotted and tested for 
significance using linear regression analysis.  
In addition to the set of blocks printed from the same material spool, we printed a 
selection of PLA blocks from different material spools to examine the magnitude of inter-
spool variations. For this test we printed 2 blocks each from 3 different PLA spools from the 
same manufacturer as the blocks described above. These blocks were also printed using the 
same Gigabot 3.0 printer as the previous blocks. We additionally printed 2 blocks each from 
3 different PLA spools from a different manufacturer (MakerBot, New York City, NY). 
These blocks were printed using a different printer, the MakerBot Replicator. All of these 
blocks’ densities and HU values were recorded, and compared with the standard blocks 
described previously. 
Printed blocks were also compared to a standard CT calibration curve used to convert 
HU values to physical density in our TPS. Differences between predicted block density (from 
the TPS calibration curve and the CT images) and actual density (based on physical 
measurement) were quantified for each block individually and for each material on average. 
The relationships between material HU and density were also tested for significance using 
linear regression analysis. 
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B. Percent Depth Dose Measurements (Validation) 
Because of the observed variation in HU and density of 3D printed blocks, we 
determined it was necessary to confirm that dose can be accurately calculated in these 
materials when the density is known. To do this we performed percent depth dose (PDD) 
measurements and then compared those measurements to TPS calculations made after 
overriding the material density. The material density in the TPS was set to that physically 
measured for each material tested. These measurements and calculations were performed in 
both NinjaFlex and PLA for 6 and 18 MV photon beams as well as 6, 9, 12, 16, and 20 MeV 
electron beams.  
We printed large blocks of PLA and NinjaFlex, including one 20 cm × 20 cm × 2.5 
cm block, two 20 cm × 5 cm × 2.5 cm blocks, a 20 cm × 2.5 cm × 5 mm strip, and a 20 cm × 
2.5 cm × 3 mm strip. Holes were incorporated into the block designs to accommodate the 
Exradin A1SL small volume ion chamber (Standard Imaging Inc., Middleton, WI). By 
stacking the various blocks in different orders, the ion chamber could be positioned at any 
depth from 1 cm to 15 cm at 1 cm increments. By using the 5 mm and 3 mm strips, smaller 
measurement increments were possible. The density of each block was also measured.  
We performed our measurements using a Varian 2100 linear accelerator (Varian 
Medical Systems, Palo Alto, CA). At each measurement point we recorded three 
measurements with our ion chamber, and for all measurements the PLA and NinjaFlex 
blocks had solid water sheets on either side to ensure scatter equilibrium. All measurements 
were done with a 100 cm source-to-surface distance, and all electron measurements were 
done using a 10 cm × 10 cm electron applicator. 
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The dose at each measurement location was calculated by following the protocol in 
the American Association of Physicists in Medicine Task Group 25 report46. Collisional 
stopping power ratios were obtained from the NIST program ESTAR47.  
We additionally acquired a CT scan of each block configuration and used our TPS, 
Pinnacle3 V9.10 (Philips Healthcare), to calculate a PDD for each energy and modality that 
we measured using the overwritten density (using the measured density of the printed blocks 
of NinjaFlex and PLA, respectively). Finally, the calculated PDD curves (with corrected 
densities) were compared with our measured PDD curves. 
 
C. Clinical Implications 
The PDD results illustrated that it is possible to accurately calculate dose in 3D 
printed materials when their density is known. In general, however, a 3D printed object’s 
density is not measured, because such measurement requires additional effort; instead, simple 
assumptions are made in clinical practice to make the workflow manageable. Our next step 
was to calculate the clinical impact of making a variety of assumptions when the true 
material density is unknown. 
To quantify the clinical impact, we defined the clinical depth error as the difference in 
millimeters between the correct 90% isodose depth (based on the true density) and a 90% 
isodose depth calculated when using incorrect (but clinically reasonable) assumptions about 
the material properties. Because 3D printed objects could be used in a number of ways, we 
decided to calculate this error for two different scenarios: a block of solid material 
(configuration 1, representing the printing of a phantom, for example), and a 3-cm block of 
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material on top of water (configuration 2, representing 3 cm of bolus placed on top of a 
patient). 
To determine the error in the clinical depth dose for each clinical assumption, dose 
deposition was calculated for each of the four materials in both configurations 1 (solid 
material) and 2 (3 cm of material over water) using 6 and 18 MV photons and 6, 9, 12, 16, 
and 20 MeV electrons on a Varian 2100.  Doses were calculated for a static 10 cm  10 cm 
field at 100 cm SSD. The 90% isodose depth for each material and energy was calculated 
based on the true density of each material and for each assumed density based on the four 
assumptions described below.  
The four assumptions considered were based on how these 3D printed materials may 
(or have) been used in clinical practice, with each assumption expected to yield greater 
accuracy but require additional effort. For each assumption, we determined what density 
would be calculated for each material and how much error that density introduced.  The 
assumptions were:  (1) the material is radiologically equivalent to water (i.e., the density of 
the material can be set to 1.0 g/cm3 in the TPS); (2) the standard CT calibration curve can 
accurately predict the material density based on the CT scan of the material (i.e., CT 
scanning the print job and relying on the TPS CT calibration curve); (3)  all blocks of a given 
material have a density equal to the average material density (i.e., measuring the physical 
density of a single print job of a given material and assuming that all other print jobs of that 
material have the same density); and (4) after acquiring a CT image, a correction factor can 
be applied to the estimated density in order to accurately calculate material density (i.e., CT 
scanning the specific print job to get density from the TPS CT calibration curve, and then 
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applying a single correction to get closer to the true density based on the average print job of 
that material). Each of these assumptions is described in greater detail below. 
The first possible assumption is that the material is water equivalent. Anecdotally, we 
have seen this assumption made, and it seems an easy simplification to make if a device was 
designed in the TPS (e.g., a piece of bolus), printed, and never imaged. For this assumption, 
we set the density of the block to 1.0, calculated the 90% isodose depths for each energy, and 
calculated the errors as described earlier in this section. 
The second possible assumption was that the CT calibration curve accurately predicts 
material density, which would be a simple approximation in clinical practice based on CT 
imaging of the print job and simply relying on the dose calculation in the TPS. For this 
assumption, we input the average HU of each material to the CT calibration curve to 
determine the average CT calibration–assumed density plus and minus two standard 
deviations for each material. We then calculated the 90% isodose depth for each of those 
three densities for each material and energy and under both configurations.  
The third assumption was that any object of a given material had the average 
measured density of that material. That is, the average density of a sample print job could be 
measured carefully once, and that value could be used as the override density in the TPS for 
any subsequent print-jobs with that material. To calculate this error, we compared the 90% 
isodose depth using the average material density to the 90% isodose depths using the average 
density plus two standard deviations and minus two standard deviations. 
The final assumption was that the correct material density could be derived by 
applying an average correction factor to the CT-estimated density. That is, each individual 
print job would be CT scanned to get a print job–specific HU. However, instead of relying on 
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the clinical HU-density calibration curve, a scaling factor would be applied based on the 
correction factor necessary to map the CT-predicted density to the true density for the 
average material. For this scenario, we calculated correction factors for each block, simply 
defined as the true density divided by the CT-estimated density. An average correction factor 
with accompanying standard deviation was calculated for each material. Next we calculated 
the density of each printed block using the CT-predicted density and average correction 
factor and then calculated the average error and standard deviation for the predicted density. 
These average density errors were used to calculate the 90% isodose depths under this 
assumption, which were again compared with the set of true depths to determine the clinical 
depth error. 
 
III.   RESULTS 
A. Material Variations 
Of the four materials studied, NinjaFlex had the largest range in measured HU values: 
178 HU between the highest and lowest recorded values. PLA was next highest, with a range 
of 121 HU. ABS and Cheetah filaments were much lower, both having a range of 30 HU 
among their blocks. The range of densities was similarly much larger for both PLA and 
NinjaFlex than for ABS and Cheetah. The density ranges for each of the materials are shown 
in Figure 3.2. 
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Figure 3.2: The spread in measured density values among the 10 blocks of each material. 
The solid filled point is the average measured density, and the high and low unfilled points 
are the maximum and minimum measured density values, respectively. The error bars around 
the average density point show the standard deviation in measured density values. 
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Overall, the range in HU drift from week to week was much smaller than the range in 
HU values in the original measurements, regardless of storage medium. The average HU drift 
of each material and storage type is shown in Figure 3.3. In general, the average HU 
decreased for blocks stored with desiccant and increased for blocks stored in open boxes. 
However, linear regression analysis on each of these lines identified only two statistically 
significant trends: ABS b (P=0.0006) and NinjaFlex b (P=0.002), both stored in open boxes.  
Even for these two samples that showed a statistically significant increase in HU as a 
function of time, however, the HU changed by only ~15 HU over the full course of 5 weeks. 
These changes were small compared to the variation among print jobs, which could exceed 
100 HU. As the magnitude of variation is small and is not highly contingent on storage 
technique, we decided to focus our error calculations on differences in the original sample, 
not on differences caused by drift over time. 
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Figure 3.3: The change in average HU relative to its original measured value for each 
material in each storage configuration. Average HU drift for materials stored in sealed bags 
with desiccant are shown as solid lines, and are labeled as “a” lines. Average HU drift for 
materials stored in open boxes are shows as dotted lines are labeled as “b” lines. The only 
statistically significant trends were ABS b (P=0.0006) and NinjaFlex b (P=0.002). 
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As HU varied between print jobs (Figure 3.2), so too did the measured density of 
each block. In general, the density of each material scaled linearly with measured HU (Table 
3.1). 
 
Table 3.1: Slope, R2, and P-values from linear regression analysis between HU and density 
for each material. 
Material Slope ((g/cm3)/HU) R-Squared P-Value 
PLA 5.9  10-4 0.96 3.9  10-8 
NinjaFlex 7.9  10-4 0.95 1.2  10-6 
ABS 4.9  10-4 0.24 0.10 
Cheetah 7.6  10-4 0.66 4.4  10-3 
 
This strong correlation between density and measured HU value implies that 
variations in HU are due to small variations in the filament size or printing conditions during 
printing and not to chemical differences in material that could have happened during printing. 
The exception to this finding is ABS. However, ABS also had the smallest recorded range in 
both HU values and densities, so this variation is less of a concern in general. 
The larger concern with material density and HU is how this relationship compares 
with a standard CT calibration curve. Figure 3.4 shows a solid line representing the standard 
CT calibration curve used at our institution for the CT scanner used in this study, as well as 
data points representing each of the materials we studied. The purpose of a CT calibration 
curve is to translate the HU value input from a CT scan to estimate a material density that 
will then be used by the TPS. For a material to be accurately modeled by the TPS, it must be 
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accurately represented by this curve. Figure 3.4 clearly shows that none of the materials we 
studied falls cleanly on this calibration curve. For the CT calibration to accurately predict 
density, an average correction factor of 1.058, 1.047, 1.028, or 1.041 is required for PLA, 
NinjaFlex, ABS, or Cheetah, respectively. 
The PLA blocks printed from different material spools from the same manufacturer 
fell within the previously described range, with average HU values of 161, 172, and 187. The 
blocks printed on a different printer using PLA were different, with average HU values of 19, 
29, and 141. The densities of all of these blocks had correspondingly large ranges, but 
followed the linear relationship with HU for PLA shown in Table 3.1.  
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Figure 3.4: 3D printed plastics plotted on a standard CT calibration curve. This figure shows 
how poorly standard calibration curves model 3D printed material properties. The CT 
calibration curve used at our institution for the CT scanner used in this study is shown as the 
solid black line. Red squares represent PLA blocks, blue stars represent Cheetah blocks, 
purple crosses represent NinjaFlex blocks, and green triangles represent ABS blocks. Note 
that, for all materials, the CT calibration curve would underestimate the material density. 
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B. Percent Depth Dose Measurements (Validation) 
When the density of the PLA blocks was overwritten in the TPS to match the 
measured density of the actual blocks used to make the PDD measurements, the calculated 
and measured curves matched within 2 mm everywhere and within 1 mm at the 90% depth43. 
As can be seen in Figure 3.5a (NinjaFlex) and 3.5b (PLA), we observed similarly good 
agreement in NinjaFlex between the measured and calculated PDD curves when we manually 
assigned the density in the TPS. Again, the measured and calculated PDDs matched within 2 
mm everywhere and within 1 mm at the 90% depth. 
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Figure 3.5: Calculated and Measured Percent depth dose (PDD) curves for NinjaFlex and PLA. Density-corrected calculated PDD 
curves are shown as solid lines, and our measured points are shown as separate squares. Panel (A) shows NinjaFlex results, and panel 
(B) shows PLA results. 
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C. Clinical Implications 
Table 3.2 shows the range of measured clinical depth errors for the four different 
clinical management assumptions considered here, for both solid material and 3-cm slab 
configurations, and for the full range of clinical electron and photon energies, in PLA, 
NinjaFlex, ABS, and Cheetah. 
When assuming that the material was water-equivalent, the overall average error 
across energy and material was 4.1 mm. The error was greatest for PLA in an 18 MV photon 
beam, reaching a maximum of 9.0 mm. When assuming that the TPS could accurately 
calculate the dose based on the CT scan, the average error across all energies and materials 
was 1.8 mm. The error was greatest for Cheetah in an 18 MV photon beam, reaching a 
maximum of 4.0 mm. When assuming that each print job had the same average material 
density, the average error was 1.2 mm. The greatest error was 3.2 mm, which was observed 
in NinjaFlex for both 18 MV photons and 20 MeV electrons. When assuming that an average 
correction factor can be applied to the CT calibration–predicted density, the average error 
was 0.7 mm. The greatest error in this case was 2.7 mm, for NinjaFlex in a 20 MeV electron 
beam. As can be seen in Table 3.2, these errors depend strongly on energy and material, but 
the general trend holds that assuming a material to be water-equivalent, which is the easiest 
assumption in clinical practice, was the worst option; using an average density correction 
factor, which is the most involved process in clinical practice (other than physically 
measuring the density of every individual print job) was the most accurate option. The 
measured errors also tended to be larger for 18 MV than 6 MV and at higher electron 
energies.  
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Table 3.2: Summary of errors associated with different quality assurance assumptions, 
materials, and modalities. All errors are reported in millimeters of 90% isodose line shift. 
Assumptions Material=H2O CT calc is correct Average density Use average corr. 
Material 
Configuration 
3cm+H2O Solid 3cm+H2O Solid 3cm+H2O Solid 3cm+H2O Solid 
6 MV PLA 3.1 4.7 0.9 0.9 0.6 1.4 0.2 0.8 
Ninja 3.1 3.6 0.4 1.6 1.8 1.6 1.4 0.5 
ABS 1.0 1.0 1.1 1.1 0.5 0.7 0.5 0.7 
Cheetah 2.7 3.8 1.1 1.6 0.3 0.5 0.3 0.3 
18 MV PLA 6.5 9.0 2.6 3.4 1.5 2.0 0.5 0.8 
Ninja 6.0 6.4 1.7 2.8 3.7 3.2 1.8 1.4 
ABS 0.9 1.4 1.6 2.0 0.7 0.9 0.5 0.7 
Cheetah 5.7 7.3 3.2 4.0 0.7 1.0 0.6 1.2 
6 MeV PLA 2.9 2.9 0.8 0.8 0.6 0.6 0.2 0.2 
Ninja 2.3 2.3 1.4 1.4 1.4 1.4 0.4 0.4 
ABS 0.7 0.7 0.9 0.9 0.7 0.7 0.5 0.5 
Cheetah 2.5 2.5 0.9 0.9 0.5 0.5 0.3 0.3 
9 MeV PLA 4.7 4.7 0.9 0.9 1.0 1.0 0.4 0.4 
Ninja 3.9 3.9 2.1 2.1 1.9 1.9 0.7 0.7 
ABS 0.9 0.9 1.6 1.3 0.7 0.7 0.3 0.3 
Cheetah 3.9 3.9 1.6 1.6 0.3 0.3 0.3 0.3 
12 MeV PLA 5.9 6.3 1.5 1.4 1.1 1.2 0.7 0.6 
Ninja 4.6 4.6 1.9 2.5 1.9 2.3 0.9 0.9 
ABS 0.9 1.4 1.6 1.8 0.4 0.9 0.5 0.5 
Cheetah 4.8 5.0 2.3 2.1 0.4 0.4 0.5 0.2 
16 MeV PLA 6.5 7.9 1.5 2.3 1.5 1.4 0.7 0.6 
Ninja 5.8 6.0 1.4 3.2 3.0 3.2 2.0 1.1 
ABS 1.1 1.3 1.6 2.3 0.7 1.1 0.2 0.5 
Cheetah 5.5 6.7 2.6 2.8 0.5 0.7 0.5 0.7 
20 MeV PLA 6.8 8.4 2.1 2.6 1.3 1.5 0.7 0.5 
Ninja 6.2 6.2 1.2 3.2 3.4 3.2 2.7 1.6 
ABS 1.4 1.8 2.6 2.9 1.2 1.4 0.7 0.7 
Cheetah 5.7 6.9 2.8 3.0 0.7 0.7 0.7 0.7 
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To further illustrate the potential error in assuming a material is water-equivalent, 
Figure 3.6 shows our measured PDD curves in NinjaFlex and PLA compared to the standard 
water PDD curves used in commissioning this linear accelerator. For those particular blocks, 
the water curves severely overestimate dose in PLA and underestimate dose in NinjaFlex. 
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Figure 3.6: Percent depth dose curves for NinjaFlex, PLA, and water. This figure demonstrates how poor of an assumption it is to 
make that either NinjaFlex or PLA are radiologically water equivalent. Measured NinjaFlex points are shown as squares, measured 
PLA points as triangles, and standard water PDD curves as solid lines. 6, 9, 12, and 16 MeV PDD curves are shown because they are 
representative of the full set of measured energies.  
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IV.   DISCUSSION 
In this chapter, we examined the HU and density uncertainties of 3D printed 
materials, between blocks printed from the same material rolls and on the same 3D printer, 
and calculated the effect this uncertainty has in determining the depth of the 90% isodose line 
at a full range of clinical photon and electron energies. We have shown that printing a single 
block of a material is not sufficient to determine if a material can be used for radiation 
therapy applications, but that 3D printing materials can be safely used if proper steps are 
taken to correctly model them in the TPS. 
Our first interesting finding was that widely used materials such as PLA and 
NinjaFlex have large spreads in HU and density, even when printed from the same material 
roll and on the same 3D printer. While the spreads for the other materials we examined (ABS 
and Cheetah) were not nearly as large, there was variation there as well. We have also shown 
that density variations between filament spools are similar when using the same printer and 
manufacturer, but can be quite different for a different printer and manufacturer. It is an 
important point that many factors can affect HU and density. Using a different printer, using 
filament from a different manufacturer, or even different rolls of the same filament from the 
same manufacturer, can all strongly affect the properties of printed objects. This indicates 
that every 3D printed object may require individual characterization; characterizing a 
material once does not guarantee that its properties will be the same in subsequent print jobs. 
Despite this large range in initially measured HU values, the blocks were much more 
stable over time after printing, with a maximum change of 16 HU (compared with a 
minimum initial range of 30 HU and maximum of 178 HU). Also interesting was that the HU 
drift over time was not strongly dependent on storage environment. These two findings lead 
us to believe that, after initial characterization of the printed objects, the properties of 3D 
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printing materials do not change substantially and no special storage conditions are 
necessary. To be entirely safe, an object that has not been used for several months may 
require reexamination before being used again.  
The most important findings in our study relate to the various potential quality 
assurance steps that need to be taken to adequately characterize a 3D printed object. In Figure 
3.5 (also see Chapter 4), we have shown that 3D printed materials can be accurately modeled 
by the TPS provided that the correct material density is known and used. It is important to 
note that, in the 3D printing setting, a material’s HU value alone is not sufficient to achieve 
accurate dose calculation accuracy, because the relationship between HU and density does 
not follow the traditional CT calibration curve. Table 3.2 and Figure 3.6 show that, when 
material density is not correctly assigned, potentially large errors can occur. Depending on 
the needs of an individual clinic, some of our measured errors may be acceptable. At a 
minimum, however, it should not be considered acceptable to assume that 3D printed 
materials are water-equivalent, or that the TPS will accurately manage these materials using 
clinical CT calibration curves. For optimal results, every 3D printed object should be CT-
imaged and have its physical density measured. We do not believe this is an overly large 
burden because, in designing a 3D printable object, the exact designed volume will be 
known, and even complex 3D printed objects print with very small volumetric errors23, 43. 
Precise scales are also relatively inexpensive. By knowing the density and CT information 
for each object, this source of potential error can be effectively eliminated. 
Another advantage of acquiring a CT image of every object is that it allows a review 
of the density and HU homogeneity throughout the printed object. Severe internal errors are 
not a common finding; Zou et al.23 found these internal block variations accounted for a shift 
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of the 90% isodose of less than 1 mm.  Nevertheless, such a step provides an additional layer 
of quality assurance and may be particularly important when implementing a new material or 
printing technique into a 3D printing workflow. 
A limitation of this study is that we considered only four of the many materials that 
can and have been used for these applications. Additionally, the precise error measurements 
that we made are only truly applicable to our printing workflow and machines. A different 
TPS, CT scanner, or 3D printer may change these results. However, we believe that the 
general magnitude of error, and especially the ranking of errors, will likely remain stable 
across platforms. For example, if another clinic finds its errors are larger when assuming a 
material is water-equivalent than what we have presented here, the best choice is still to 
measure and manually assign its density in the TPS.  Nonetheless, this chapter provides 
guidance for evaluating materials for radiotherapy applications and the overall clinical effect 
of various assumptions in the treatment planning process. 
 
V.   CONCLUSIONS  
Our results show that a variety of 3D printed materials can be used safely to create 
patient-specific phantoms or radiotherapy devices under certain conditions. Specifically, each 
material and print process must be carefully characterized for both the spread in HU values 
and densities. We found that when poor assumptions are made about 3D printed materials, 
errors in the 90% isodose position could be as large as 1 cm. Assumptions that should be 
avoided are that 3D printed materials are water-equivalent, or that the clinical CT calibration 
curve can accurately determine the density of 3D printed materials. When correct steps were 
taken to account for these plastics’ special relationship of density to HU, 90% isodose 
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position errors were generally less than 1 mm. In conclusion, 3D printing technology can be 
extremely useful in creating innovative research and clinical tools in radiotherapy, but care 
needs to be taken to ensure that dose calculations involving these devices are accurate.   
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Chapter 4: Phantom Development 
This chapter is based upon the following publication, with additional material provided to 
detail multiple phantoms being printed: 
D.F. Craft and R.M. Howell, “Preparation and fabrication of a full-scale, sagittal-sliced, 3D-
printed, patient-specific radiotherapy phantom,” Journal of Applied Clinical Medical Physics. 
Volume 18, issue 5, pages 285-292. 2017. © The Authors. 
The permission for reuse of this material was obtained from the authors. 
 This chapter describes the results of Specific Aim 2: Design and fabricate a sample of 
patient-specific, whole body phantoms of PMRT patients.  
I.   INTRODUCTION 
In radiation therapy, commercially available anthropomorphic phantoms can be used 
for end-to-end quality assurance (QA) of new treatment techniques. Such phantoms are 
generally available in only four forms: male, female, child, and infant. These phantoms have 
average body mass indices, but most patients’ individual anatomy differs greatly from that of 
the representative phantoms. For example, a post-mastectomy woman with a high body mass 
index is not accurately represented by the standard adult female phantom. A patient-specific 
phantom that accurately represents an individual’s specific anatomy has greater validity than 
the standard phantom as a model in a variety of research and clinical applications. Patient-
specific phantoms have many potential uses in radiotherapy but are generally not 
commercially available. This lack can be attributed to the development time and expense 
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required to individualize the production process. Three-dimensional (3D) printing is one tool 
that potentially can be used to inexpensively custom-fabricate patient-specific phantoms.  
Several studies published in recent years have shown the advantages of 3D printed 
phantoms for use in radiotherapy and in other areas of medicine. Ehler et al.27 printed a shell 
of a generalized head and filled it with wax to be used for intensity-modulated radiation 
therapy QA. Ger et al.48 also printed a shell of a head, but filled it with variable-density 
materials to make a heterogeneous head phantom. Similarly, Gear et al.28 printed liquid-
fillable shells, but of patient-specific organs, to be used as molecular imaging phantoms. 
Nattagh et al.29 created a training phantom for ultrasound-guided needle insertion and 
suturing during gynecologic brachytherapy procedures. As proposed by Burleson et al.24, 3D 
printed exterior molds of a patient can be useful as a way to fit electron bolus before 
treatment for patients with open wounds or sensitive skin.  3D printed patient-specific 
phantoms have also been found to be helpful in surgical planning49 and in the education of 
medical residents for surgeries of the liver50 and brain51. In general, patient-specific 
phantoms could be used not only for end-to-end QA of new radiation therapy techniques but 
also to perform QA for routine treatments on patients with highly atypical anatomy25. 
Despite the conceptual simplicity of 3D printed patient-specific phantoms, they have 
several key limitations. Two of these are the small size of most commercially available 3D 
printers23 and the tendency of printed objects to warp or become distorted while printing24. 
Warping happens because of the way objects are printed in successive layers. Different layers 
cool and contract at different rates, causing the object being printed to curl upward from the 
build platform as layers separate from each other. In severe cases, the warping object can 
impede the path of the extruder and cause the model to stop printing. In other cases, this 
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warping is minor, affecting only the bottom few layers. The warping effect is heightened 
when large surfaces of the object being printed are in contact with the print bed. Warping is 
also much more problematic when an object is being printed at 100% infill (solid) rather than 
at a lower infill percentage or as a hollow shell. Warping is most prevalent with 3D printers 
that use fused deposition modeling technology, but other printing technologies, like 
stereolithography, are generally even more limited in total print volumes making them 
impossible to use for large phantoms. 
Many of the published studies have minimized the impact of warping by printing only 
a shell of the phantom and then filling it with water or wax. These liquid-filled phantoms are 
more complicated to design, however, and are homogenous without internal air gaps. 
Additionally, all of the reported studies of 3D-printed phantoms are for small anatomical 
regions (i.e., head or smaller), where the impact of warping is minimal. The goal of this 
chapter was to develop and test a 3D printing workflow with minimal warping error that can 
be used to print any large anatomical region with 100% infill representing tissue, while 
allowing for inclusion of low-density air-filled regions. Then, using that workflow we aimed 
to design and print a set of six full-sized patient-specific phantoms based on PMRT patients. 
Throughout this chapter we will detail the steps taken to print the first phantom, then 
summarize the results of all six. 
 
II.   MATERIALS AND METHODS 
We printed the first phantom as eleven 2.5-cm-thick sagittal slices, with the inferior 
aspect of each slice in contact with the print bed. This approach was chosen with the goal of 
minimizing the extent and effects of material warping on our phantom. 3D printed objects 
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warp primarily from their contact with the print bed, so orienting all the slices in the sagittal 
plane accomplishes two things. First, only 2.5 cm of the slices make contact with the print 
bed, rather than the entire width of the phantom, so there is less overall surface area to warp. 
Second, because any warping that does occur is localized to the inferior aspect of the slice, it 
doesn’t obstruct the contact points between slices. The superiority of sagittal slices over axial 
slices in respect to warping is illustrated in Figure 4.1.  
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Figure 4.1. Slice orientation and material warping. This is a representation of what a square 
phantom might look like if printed in different orientations. (a) and (b) show how warping 
could affect slices printed in the axial and sagittal planes, respectively, due to the edges 
curling up from the print bed. All parts are shown as if they were printed with their inferior 
aspect in contact with the print bed. Note that in (b) there is overall less warping from the 
desired square, and the warping that does happen doesn’t affect the contact between slices. 
(c) is a picture of a 3D printed block with warping observed on the edges that were in contact 
with the printing bed during printing.  
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A. 3D Printing File Preparation  
We designed our first printed phantom directly from a computed tomography (CT) 
image of a 76-year-old woman who had undergone a left-sided mastectomy. This patient 
(and all others for whom we printed phantoms) is part of an Institutional Review Board–
approved cohort of patients for retrospective studies. The first step in developing ready-to-
print files was to export the patient-of-interest’s DICOM data from the clinical planning 
system, Pinnacle3 (Philips Healthcare; Andover, MA), to the DICOM imaging software 
OsiriX (Pixmeo; Bernex, Switzerland). The sequence of steps is diagramed in Figure 4.2.  
 
 
Figure 4.2. Workflow diagram showing the steps and software used to prepare files for 3D 
printing, from treatment planning (TPS) to product. 
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Using OsiriX’s voxel value reassignment function, we set the Hounsfield unit (HU) 
value of voxels outside the area of interest to -1024. This effectively cropped those areas 
from the final 3D skin rendering. We cropped the arms to simplify printing and the head to 
preserve patient anonymity. Once the CT image was processed within OsiriX, we used the 
3D surface rendering function to produce a 3D model of the image for all voxels with an HU 
above a threshold of -500. That threshold value keeps all soft tissue and bone as one material, 
but leaves open air cavities such as the trachea and lungs. This whole-body model was then 
exported to the 3D model manipulation software netfabb (netfabb GmbH; Parsberg, 
Germany), now Autodesk (San Rafael, CA).  
Netfabb has a special cutting function that we used to slice the original whole-body 
model into 2.5-cm-thick sagittal slices. Each individual slice was then exported into 
MeshLab, another 3D model manipulation program. This open source and free to use system 
developed by the 3D-CoForm project allows piece-by-piece editing and cropping. In 
MeshLab, each slice was examined for any overhanging or free-hanging parts that would 
cause printing errors. For example, sagittal slices that intersect the lungs often left parts of 
the bronchi unsupported, so those parts were deleted. These sections were generally small. 
Once every slice was cleared of overhanging parts, they were transferred to Simplify3D 
(Simplify3D; Cincinnati, OH). This software translates 3D models into g code, the language 
used by our 3D printer to define print jobs. Each slice was oriented with its flat 2.5-cm-thick 
inferior aspect on the print bed. The print-ready files were saved onto an SD card. 
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B. Phantom Fabrication 
All slices were printed by a Gigabot 2.0 printer (re:3D; Houston, TX). The Gigabot 
has the capacity to print objects with dimensions up to 60 cm × 60 cm × 54 cm (x, y, z) with 
a layer resolution of 100–300 microns and x-y resolution of 4 microns. This build volume is 
much larger than those used in previous studies27, 28, 31. Each slice was printed with a 300-
micron layer resolution at 100% infill using 2.85 mm polylactic acid (PLA) filament (re:3D; 
Houston, TX).  Many different materials’ radiological properties have been studied, but the 
two most widely used are PLA and acrylonitrile butadiene styrene (ABS). Both materials are 
nearly identical in price and printing speed, and both have similar radiological properties to 
water23, 24, 27, 52. However, ABS warps considerably more than PLA which makes it extremely 
difficult to use for large objects printed at solid infill24, 53. PLA was chosen primarily for its 
superior warping characteristics, and the fact that we have previously shown in Chapter 3 
that we can accurately model it in our TPS. 
The settings used by the printer can strongly affect the degree of warping observed, 
so each of the settings used by this experiment were informed based on previous experience.  
Many objects were printed with solid infill using various settings, and the settings below 
were found to be the best practice for minimizing warping and limiting print failures. The 
printing bed was set to 60°C and the print nozzle to 225°C. The extrusion multiplier, or flow 
rate, was set to 90%, and the nozzle’s print speed was 60 mm/sec. The printing bed is made 
of BuildTak (Ideal Jacobs Corporation, Maplewood, NJ), but unlike many other experiments 
with 3D printing, no other tape or adhesive was applied to the bed. As each slice was printed, 
we recorded the total time to print it, the mass of the material used, and the total cost of the 
material. Average slice and total phantom printing parameters were then calculated. After the 
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3D printing was completed, we drilled two holes across each slice so that plastic 
immobilization rods could be placed to hold the phantom slices together. We additionally 
drilled 17 holes for TLD to be placed throughout the phantom: 9 in the chest wall, 3 in the 
heart, and 5 in the intact right breast. For the subsequent phantoms 2-6 these immobilization 
rod holes and TLD holes were incorporated into the initial design and did not need to be 
drilled after printing. 
 
C. Material Analysis 
To determine the attenuation properties of the PLA material used for the phantom, we 
printed several 5 cm × 5 cm × 5 cm cubes of PLA. The cubes were imaged on a Phillips 
Brilliance Big Bore CT scanner (Philips Healthcare, Andover, Massachusetts). The CT 
number of each block was recorded, and the blocks were weighed and measured to determine 
their volume, density, and print accuracy. Percent depth doses measurements were also 
performed on PLA as reported earlier in Chapter 3. 
 
D. Phantom Verification 
We evaluated the first phantom’s slices both individually and collectively. Before 
drilling the holes for the placement of the immobilization rods, a CT scan was acquired of 
each individual slice on a Philips Brilliance Big Bore (Philips Healthcare; Andover, MA). 
We also measured the thickness of each slice at its superior, anterior, and inferior aspects 
with sub-millimeter resolution calipers. We defined the per-slice printing accuracy in two 
ways: measured accuracy and volumetric accuracy. The measured accuracy was defined by 
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calculating the average discrepancy between the measured and planned thicknesses at the 
top, middle, and bottom of each slice. The volumetric accuracy of each phantom slice was 
defined by comparing the volume of the 3D rendering of the CT scan with the model created 
for printing. 
After the rods were placed, we acquired a CT scan of the entire phantom. The 
assembled phantom accuracy was evaluated by registering its CT image with the original 
patient CT image and examining the slice-by-slice alignment in all three planes. 
Additionally, average CT numbers were measured throughout the phantom and patient 
images to determine the CT number discrepancy in various anatomic regions. 
 
III.   RESULTS 
A. 3D Printing File Preparation 
Preparing the eleven slices from the original CT data was straightforward and simple. 
The process of cropping the CT scan, converting it to a 3D model, and slicing it into 2.5-cm 
slices took less than 30 minutes once we were familiar with the workflow. Preparing each 
individual slice for printing took slightly longer, approximately 10 minutes per slice, or 2 
hours in total. In total, preparing all 6 phantoms took approximately 12 hours of work. 
B. Phantom Fabrication 
Each slice printed correctly on its first attempt with the same settings. Pictures of the 
first printed phantom before and after the immobilization rods were placed are shown in 
Figure 4.3. The slices fit together well, and a high degree of detail was preserved. Figure 4.4 
shows all the printed phantoms.  
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Figure 4.3: Photographs of a 3D printed phantom. (a) and (b) show the entire phantom 
before and after placement of immobilization rods, respectively. Note that gaps between 
slices were significantly reduced with the application of the immobilization rods. (c) shows a 
view of the phantom with the two left-most slices removed, and (d) shows an individual 
slice. 
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Figure 4.4: Photographs of the set of 6 3D printed PMRT phantoms. Panels (a) and (b) are 
from patients with BMI category 2 (normal weight), panels (c) and (d) are from patients with 
BMI category 3 (overweight), and panels (e) and (f) are from patients with BMI category 4 
(obese). 
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The time to print each slice, the mass of each slice, and the cost of each slice are 
reported in Table 4.1. In total, the first phantom took 267.5 hours to print, weighed 12.53 kg, 
and cost $524 in raw materials. Table 4.2 summarizes these statistics for all 6 phantoms that 
we printed. 
Table 4.1: Print statistics for each individual slice, average, and total.  
Slice Print Time (hr:min) Mass (g) Cost (US dollars) 
1 31:41 1520.85 63.57 
2 19:24 899.63 37.60 
3 16:42 767.35 32.08 
4 19:19 884.90 36.99 
5 30:56 1446.55 60.47 
6 35:14 1666.45 69.66 
7 27:23 1267.11 52.97 
8 19:48 913.50 38.18 
9 17:28 801.73 33.51 
10 22:28 1061.45 44.37 
11 27:07 1296.15 54.18 
Average 24:19 1138.70 47.60 
Total 267:30 12,525.67 523.58 
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Table 4.2: Individual, average, and aggregate print statistics for each phantom.  
Phantom BMI 
Category 
Print Time 
(hr:min) 
Slices Mass (kg) Cost (US 
dollars) 
1 2 267:30 11 12.53 523.58 
2 2 284:59 11 12.97 542.28 
3 3 346:22 12 15.88 663.62 
4 3 339:00 13 15.39 643.52 
5 4 410:37 13 18.81 786.11 
6 4 415:37 13 19.00 794.33 
Average 3 344:00 12.17 15.73 658.91 
Total NA 2064:05 73 94.58 3953.44 
 
 
C. Material Analysis 
We found that the printed PLA blocks had a mean HU of 160±12, a physical density 
of 1.20 relative to water, and print errors of 1.09 mm on average. 
The treatment planning system calculated PDDs and the measured PDDs agreed 
within 2 mm for all electron energies. The 6 and 18 MV photon beams measurements and 
calculations agreed within 2% Figure 3.5). 
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D. Phantom Verification 
The measured slice errors were all positive, meaning the slices were consistently 
larger than planned, and ranged from 0.44 mm-0.60 mm, with an average of 0.52 mm across 
all eleven slices. The average error at the bottom of the slices was 0.76 mm, while the errors 
at the middle and top were 0.51 mm and 0.29 mm, respectively. The decreasing error as the 
slice gets further from the print bed is consistent with previous observations that more 
warping occurs at the contact point between the printing surface and the object being printed. 
The volumetric errors of the individual slices ranged from 0.75%–1.83%, with an average 
across all slices of 1.37%. The slices printed relatively homogenously, and had a mean HU of 
155 with a standard deviation of 18. Figure 4.5 shows an image of one slice as it was planned 
and as it was imaged. 
There was excellent agreement between the original patient CT scan and the 
assembled phantom CT scan for all 6 phantoms. Figure 4.6 shows slices of each CT scan 
next to each other for phantom 1, as well as the 3D model of the imaged phantom and 
original patient. The only disagreement between the phantom and patient data sets was in the 
lungs, where unsupported nodules were cropped to make printing possible (see section II.A). 
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Figure 4.5: 3D-rendered models of slice number 1.8. (a) is the planning model used to print 
slice 8, and (b) is the model based on the CT scan of the actual printed slice. Figure 3(d) is a 
photograph of this same slice. 
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Figure 4.6: Comparison of the original patient CT scan registered with the completed 
phantom CT scan. Panels on the left show slices of the original patient CT scan, panels in the 
middle are from the CT scan of the assembled phantom, and panels on the right are the 3D 
rendered models of the original patient and the phantom. (a) and (b) compare axial slices, (c) 
and (d) compare coronal slices, and (e) and (f) compare sagittal slices. (g) and (h) compare 
rendered models of the phantom and patient CT scans, respectively. 
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The average CT numbers of the patient 1 and printed phantom 1 are reported in Table 
4.3. In general, the printed phantom had a CT number around 140 HU higher than the 
patient’s soft tissue, but is 100 HU lower than the patient’s spinal area.  The lungs of the 
phantom were also 130 HU lower than in the patient. 
 
Table 4.3: CT number measurements for patient 1 and phantom 1 images.  
Location 
Phantom CT 
Number (HU) 
Patient CT 
Number (HU) 
CT Number 
Discrepancy (HU) 
Heart 133±77 25±25 108 
Breast 82±145 -61±47 143 
Arm 133±90 -5±95 138 
Left lung -989±8 -862±90 -128 
Right lung -993±7 -861±95 -132 
Spine 132±65 227±164 -95 
 
 
IV.   DISCUSSION 
In this chapter, we successfully produced 6 patient-specific, 3D printed phantoms 
using a commercial printer and readily available software and materials. All software used in 
the design and preparation of print files was acquired or licensed for under $1000. The 
phantoms were printed in sagittal sections to minimize the impact of material warping. 
Although the overall phantoms were large (35 cm × 25 cm × 32 cm), they had minimal 
warping (<2%). Because the small amount of warping observed was primarily in the inferior 
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portion of the phantoms (closest to the print bed during printing), the individual slices were 
well aligned in the fully assembled phantom. Accurate, simple, and inexpensive phantoms 
like these could be valuable for a variety of radiotherapy applications in both research and 
clinical settings. These particular phantoms have been useful to us as a tool in developing 
breast compensators that can fit on irregular patient anatomy (see Chapter 5). Standard 
anthropomorphic phantoms are not designed to mimic patient treatment positioning, e.g., 
breast patients are simulated with their ipsilateral arm raised above the head. This type of 
patient specific phantom can be highly useful and informative in scenarios such as our 
present work designing patient-specific compensators for breast cancer and many other 
treatment sites or patient-specific QA of treatments where patients are in atypical treatment 
positions.    
Our printed phantoms differs from those described in other published work in several 
ways. Because of material warping, most 3D printed phantoms in the literature have been 
printed as a shell and then filled with liquid to make them solid27-29. Our phantoms were 
printed at 100% infill, which reduces the amount of work involved in the overall fabrication 
process. Concerns about material warping have also limited the size of most phantoms, as has 
the scarcity of large-scale 3D printers. By printing slices in the sagittal orientation on the 
recently available Gigabot 2.0, we were able to create large (up to 2.5 cm × 23 cm × 32 cm) 
solid parts while still keeping warping errors under 2%.  
One of the greatest advantages of our printed phantom is its relative cost. Including 
software, hardware, and materials, fabricating our first phantom cost less than $15,000, and 
additional phantoms cost on average $660 in materials. Traditionally manufactured standard 
anthropomorphic phantoms can cost more than $20,000, while patient-specific ones cost 
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much more. Related to cost is the simplicity of our process. The fabrication process and steps 
outlined in this study can be used on demand to rapidly design and produce not only full-
sized phantoms, but any patient-specific model of any size. 
The limitation of the phantom is that both soft tissue and bone were represented by 
PLA. While the radiological properties of PLA are between those of bone and water, PLA is 
not a perfect approximation for either. The addition of a second material to simulate bone and 
give the phantoms some heterogeneity would potentially be advantageous. Some groups have 
reported work on variable-density 3D printed phantoms, and while their work is promising, 
the variable density either has a high dependence on the direction of radiation31 or requires a 
complicated custom extrusion system and labor-intensive post-processing work48. Recently, 
we acquired a new Gigabot 3D printer with an additional extruder with the capacity to print 
with multiple materials. Future work will include the addition of multiple-material printing to 
the workflow described here. 
It is an important point to reiterate that PLA is not dosimetrically identical to water. 
Further, complex printed objects tend to have a lower HU than simple blocks, with an 
electron compensator having 107 HU compared to its 130 HU block23, and our own phantom 
having a mean HU of 133, compared to our 160 HU blocks. Additionally, PLA does not fall 
on a standard CT calibration curve due to its density of 1.20 relative to water. In order to 
accurately calculate dose in PLA the HU or physical density must be manually overwritten. 
Burleson et al. found they could accurately calculate PDDs in PLA if they set the HU to 
26024, and in our own PLA PDD measurements we similarly measured the density and set it 
to 1.20 g/cm3 in order to get accurate calculations (see Chapter 3).  In summary, the physical 
and radiological properties of PLA have been characterized and we have demonstrated that it 
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can be used to fabricate patient-specific single material radiation therapy phantoms.  While 
implementation of multi-material 3D printed phantoms would be a further improvement, 
homogeneous phantoms are at present routinely used for many types of radiation treatment 
QA.  Examples include patient-specific IMRT QA and accreditation procedures for clinical 
trials54, 55. 
Another limitation was the time required to print the phantom. While preparation was 
straightforward and not very time-consuming, printing the entire first phantom took over 11 
days and positioning rods and TLD holes had to be manually drilled. Subsequently, for 
phantoms 2-6 the positioning rod and TLD holes were designed into the original slices, 
reducing the need for post-printing manual labor. However, the full time to print all 6 
phantoms was approximately 94 days. Because of this long print time, large patient-specific 
phantoms are not currently feasible for routine patient-specific QA procedures. With a well-
defined workflow, however, in-house fabricated 3D printed phantoms can be an inexpensive, 
simple, and accurate alternative to commercially available phantoms and can be used to 
perform end-to-end QA of new radiation therapy techniques and for various research 
applications.   
 
V.   CONCLUSION 
This chapter has shown that large patient-specific phantoms can be fabricated with 
high accuracy on inexpensive, commercially available 3D printers. We successfully used real 
patient data to make six anatomically accurate, full-scale phantoms, overcoming previously 
encountered 3D printing limitations of size and material warping. Our method required no 
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customized software or materials and was simple to execute. With multiple-material 
extrusion printers, patient-specific phantoms could be improved further and could soon be a 
viable tool for many research and clinical tasks.    
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Chapter 5: Design and Validation of Physical Compensators 
This chapter is based on the following manuscript, which has been submitted to Radiotherapy 
and Oncology, and is currently under review: 
D.F. Craft, P. Balter, W. Woodward, S. F. Kry, M. Salehpour, R. Ger, M. Peters, G. Baltz, E. 
Traneus, and R.M. Howell, “Design, Fabrication, and Validation of patient-specific tissue 
compensators for postmastectomy radiation therapy,” In review. (2018). 
This chapter describes the results of Specific Aim 3: Create a tool to design patient-
specific compensators, and quantify dose distribution improvements in treatment planning 
studies relative to patients’ standard of care plans, and describes the results of Specific Aim 
4: Validate treatment planning dose distributions using the compensators from Aim 2 and the 
phantoms from Aim 3. 
 
I.   INTRODUCTION 
As mentioned in Chapter 1, post-mastectomy radiation therapy (PMRT) is the 
standard of care for node-positive breast cancer, because it has been shown to markedly 
reduce the risk of breast cancer recurrence and mortality2. However, planning and delivering 
PMRT is technically difficult. The desired radiation dose distribution should cover the chest 
wall and proximal lymph nodes but avoid the heart, lungs, and contralateral breast. 
Additionally, the chest wall thickness varies greatly, and large heterogeneities in tissue 
density must be accounted for in the treatment plan. Because of these difficulties, most 
PMRT plans involve multiple radiation fields that, despite being carefully matched, still 
result in hot and cold spots at field junctions6.  
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Tissue compensators have been applied in PMRT as one approach to reducing 
treatment complexity, improving dose homogeneity, and eliminating hot and cold spots at 
field junctions11, 13, 56. Tissue compensators have also been used for similar purposes in a 
variety of disease settings, such as cancers of the head and neck14, soft tissue sarcomas17, 
total body irradiation18, and paraspinal muscle treatment9. Tissue compensators are versatile 
because they can even out almost any surface, which makes simple, single-field treatments 
possible19. Despite the dosimetric advantages they provide, however, tissue compensators are 
not used frequently. Conventional techniques for compensator fabrication, such as wax 
molding and machine milling, are time-consuming and labor-intensive19, and quality 
assurance of compensator devices is difficult. While there is a body of literature describing 
compensator design algorithms8, 20, these methods are generally not included as part of 
commercial treatment planning software.  
Three dimensional (3D) printing technology has the potential to overcome the 
limitations of conventional fabrication techniques and reduce operational and production 
costs compared to conventional fabrication. There is a growing body of research showing 
interesting radiotherapy applications of 3D printing, including phantom production27, 28, 30, 31, 
43 and patient-specific devices20, 22, 24, 37, as well as extensive material analysis20, 44, 45, 52. 
The purpose of this chapter was to prove the clinical feasibility of using 3D printed 
patient-specific compensators to improve and simplify PMRT. Our aims were to 1) develop 
an algorithm to calculate optimal compensator shapes and export them for 3D printing, 2) 
compare dose distributions from compensator based plans and clinical plans for actual 
patients with varying BMIs, and 3) validate calculated dose distributions with physical 
measurements by delivering compensator based plans to patient-specific phantoms. 
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II.   MATERIALS AND METHODS 
A. Algorithm Design 
We designed an iterative, 4 step algorithm (Figure 5.1) to calculate patient-specific 
compensators. Between each step the user has opportunities to change settings or stop the 
script altogether. All but the end of step 4 are implemented as an internal script we wrote in 
RayStation 6R (RaySearch Laboratories, Stockholm, Sweden), which is a research version of 
the commercial TPS used in our clinic. 
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Figure 5.1: Algorithm and compensator planning flow diagram. The 4 steps of the algorithm 
are shown, as well as the progression from step 1 to step 2, the iteration between step 2 and 
step 3 until satisfactory plan conditions are met, and the final export and printing of the 
compensator as shown in step 4. 
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Before starting the script a CTV must be defined. Once started, step 1 of the script 
will automatically create a new plan and add an electron beam, and then ask the user to set an 
appropriate en face gantry angle and isocenter position. Next, the algorithm automatically 
creates ROIs designating the cerrobend block and an initial, thin, flat compensator within the 
tray. Finally, an initial dose distribution is calculated, and the algorithm moves to step 2. 
Step 2 of the algorithm modulates the shape of the compensator according to the 
previously calculated dose distribution. The difference between the actual, and prescribed 
dose is calculated at the distal edge of the CTV in a grid of user chosen size. Based on this 
dose difference, the anterior surface of the compensator is modulated along the ray line 
projected to that point. If the dose at the CTV edge is too high, the compensator thickness is 
increased, and if it is too low, the compensator thickness is decreased (with a minimum 
thickness of 1 mm). Once all grid points have been evaluated and the compensator shape 
modulated accordingly, a smoothing function is applied to reduce sharp edges. 
Step 3 recalculates the dose in the patient using the newly modulated compensator 
shape from step 2. At this point the script pauses, allowing the user to evaluate how well the 
plan meets clinical goals. If necessary, the user may change the electron energy or any other 
setting. If any settings are changed or if clinical goals are not met, the algorithm will go back 
to step 2, then return to step 3. This iterative process continues until the user is satisfied with 
the treatment plan. 
Once the treatment plan is approved, the patient’s ROI structures are exported and the 
compensator ROI is converted into a 3D model using the open-source DICOM image 
processing software 3DSlicerRT. Finally, the compensator model is prepared for 3D printing 
using the 3D slicing software Simplify3D (Simplify3D; Cincinnati, OH). 
60 
 
B. Patient Dose Comparisons 
Compensator plans were compared with conventional multi-field, multi-energy 3D 
plans for a sample of PMRT patients previously treated at our institution. As part of an 
Institutional Review Board approved protocol, we selected 8 patients consecutively from a 
population of patients treated by the American Board of Radiology (ABR)–certified 
collaborating radiation oncologist (WW) between 12/1/2014 and 12/1/2015. The patients all 
had left-sided disease, were treated with deep inspiration breath hold, and are representative 
of the body mass index range in our clinic. 
For each patient’s standard of care treatment plan various dose metrics were recorded, 
including CTV coverage, heart dose, ipsilateral and total lung dose, extent of hot spots, skin 
dose, and CTV heterogeneity index. Heterogeneity index is defined according to Equation 
157. 
1)          𝐻𝐼 = 100 ∗ 
𝐷2 − 𝐷98
𝐷𝑝
 
D2, D98, and Dp stand for the minimum dose in 2% of the CTV (essentially the 
maximum CTV dose), minimum dose in 98% of the CTV (essentially the minimum CTV 
dose), and the prescription dose, respectively. 
A new plan was then created for each patient using the algorithm described above, 
and the same dose statistics were recorded. Differences between each dose metric were tested 
for statistical significance using paired t-tests with an applied Bonferroni correction. 
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C. Film Profile Measurements 
Due to the relatively rapid dose fall off in the distal edge of electron beams, we 
wanted to ensure we could accurately model the dose profile in patients when using 
compensator devices. To do this we designed a simple wedge shaped compensator in the 
TPS, printed it in polylactic acid (PLA), poured cerrobend around it to affix it in the electron 
tray, and measured dose profiles in solid water using GAFchromic (Ashland, Bridgewater, 
NJ) film. We calibrated our film response using a 16 MeV electron beam in standard output 
check conditions. Film profiles were measured by placing film in line with the electron beam, 
surrounded by solid water. Five total sheets were irradiated; one at 12 MeV, three at 16 MeV, 
and one at 20 MeV. Measured dose profiles were compared with the TPS calculated profiles. 
 
D. Phantom Validation Measurements 
In order to validate the full complexity of patient-specific compensators we designed 
compensator plans and printed physical compensators for 6 patient-specific anthropomorphic 
phantoms. Two phantoms each were based on patients in BMI category 2 (normal weight), 
category 3 (overweight) and category 4 (obese). These phantoms were 3D printed using our 
previously developed methods as described in Chapter 4, and were based on the same 
population of patients described earlier. Both the phantoms and compensators were printed 
out of PLA using a Gigabot 3.0 printer (re3D, Houston, TX). 
Each phantom was loaded with 20 TLD detectors placed throughout the CTV, heart, 
contralateral breast, and skin. For each phantom the compensator plan was delivered as 
designed by the previously described algorithm using a Varian TrueBeam linear accelerator 
(Varian Medical Systems, Inc., Palo Alto, CA), and the TLD were analyzed following the 
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methodology described by Kirby et al.58, having an uncertainty of <2.3%. Dose was also 
recorded in the TPS for each TLD location in the phantom, and these calculated and 
measured values were compared to determine the ability of the TPS to accurately model dose 
in patients for compensator based PMRT plans. The final phantom doses were calculated 
with the measured density of the printed phantom corrected in the TPS, according to 
recommendations regarding 3D printed devices previously described in Chapter 3. 
 
III.   RESULTS 
A. Patient Dose Comparisons 
Compared to the standard of care clinical plans, the compensator based plans on 
average had superior dose coverage of the CTV with reduced hot spots. Statistically 
significant (p<0.0025) improvements were achieved for CTV coverage, reduced hot spots in 
the lungs, and heterogeneity indices. Results are summarized in Table 5.1. 
Figure 5.2 shows all 8 patients’ averaged dose volume histograms comparing the 
conventional 3D plan and the compensator based plan.  As can be seen in the figure, CTV 
coverage is improved, while high dose regions in the lungs and CTV are reduced. 
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Table 5.1: Comparison of dose metrics between conventional 3D plans and compensator 
based plans. 
Dose Metric Average 3D 
Plan 
Average Comp 
Plan 
Average 
Difference 
(Comp-3D) 
p-value 
CTV D98 3900 cGy 4456 cGy 555 cGy 0.001 
CTV Mean 
Dose 
5231 cGy 5305 cGy 74 cGy 0.115 
CTV D2 6719 cGy 6251 cGy -468 cGy 0.056 
CTV V45 Gy 89.07% 97.08% 8.01% 0.001 
Heart Mean 
Dose 
280 cGy 296 cGy 16 cGy 0.387 
Heart V30 Gy 0.01% 0.31% 0.30% 0.057 
Ips. Lung D2 5209 cGy 3897 cGy -1312 cGy 2.93E-5 
Ips. Lung V20 
Gy 
30.64% 34.30% 3.66% 0.135 
Ips. Lung V40 
Gy 
13.31% 1.69% -11.63% 9.0E-5 
Total Lung 
Mean Dose 
748 cGy 760 cGy 12 cGy 0.438 
Skin Mean Dose 4078 cGy 5223 cGy 1145 cGy 4.6E-4 
Skin D2 5773 cGy 6209 cGy 436 cGy 0.017 
HI 56.4 35.9 -20.5 6.1E-4 
110% Hotspot 
Volume 
257 cm^3 170 cm^3 -87 cm^3 0.076 
130% Hotspot 
Volume 
32 cm^3 5 cm^3 -27 cm^3 0.087 
150% Hotspot 
Volume 
8 cm^3 0 cm^3 -8 cm^3 0.156 
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Figure 5.2: Cumulative DVH comparison. The average of all compensator plan DVHs are shown with dotted lines, while the average 
of all conventional 3D plans are shown as solid lines. The average standard deviation for conventional 3D plans was 2.47%, and for 
compensator plans it was 4.00%. 
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B. Film Profile Measurements 
Measured and calculated film dose profiles were compared in 5 ways: depth of the 
central 80% isodose line, width of the 80% isodose line, and depth of the 80% isodse line 2 
cm to the left and to the right of the central line. The average differences between calculated 
and measured dose profiles are shown in Table 5.2. Film measurements and TPS calculations 
agreed on average within 2 mm for all energies examined. 
 
C. Phantom Validation Measurements 
3D printed compensators took 10-15 hours to print, and material costs averaged $30. 
Figure 5.3 shows photographs of a phantom and compensator plan, and TLD results are 
summarized in Table 5.3. Average disagreement between TPS and TLD doses in the CTV 
was 2.3%, and measured TLD doses outside the treatment area (heart and contralateral 
breast) agreed with TPS calculations within 16.9%. Skin TLD pack doses agreed with the 
TPS within 2.88%.  
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Table 5.2: Film profile measurements and calculation errors. 
Energy (MeV) Average Error (mm) Standard Deviation (mm) 
12 1.27 0.87 
16 1.99 1.25 
20 1.95 1.17 
Average 1.78 1.23 
 
 
 
Table 5.3: Summary of TLD dose calculation and measurement error 
Phantom Average  
In-field 
TLD 
Error 
In-field 
TLD 
Error SD 
Average 
Out-of-
field TLD 
Error 
Out-of-
field 
Error SD 
Average 
Skin TLD 
Error 
Skin 
Error SD 
1 1.2% 1.2% 15.7% 8.8% NA NA 
2 2.5% 1.4% 9.7% 6.6% 1.8% 0.6% 
3 2.1% 1.4% 25.0% 24.8% 4.6% 2.0% 
4 2.1% 1.3% 20.0% 11.6% 2.7% 1.3% 
5 3.5% 2.2% 23.7% 17.0% 3.9% 1.0% 
6 2.3% 1.7% 7.2% 9.2% 1.5% 1.8% 
Average 2.3% 1.5% 16.9% 13.0% 2.9% 1.4% 
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Figure 5.3: Compensator plan delivery to a phantom. A) Photograph of the compensator in 
the cerrobend tray. B) Photograph of the compensator and phantom in treatment position, and 
C) Slice of the TPS view of the plan. In (C) the compensator is contoured in orange, the 
cerrobend in dark blue, the CTV in light blue, and the heart in pink. 
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IV.   DISCUSSION 
In this chapter we developed an in-house algorithm scripted within a commercial TPS 
to design patient-specific, 3D printable compensators for PMRT. These compensators are 
unique in that they are designed to fit within a standard electron tray, meaning we can use 
fast-printing, rigid materials that won’t come in contact with the patient surface. We 
additionally validated the dosimetry of the algorithm and 3D printed materials using film 
measurements in solid water and TLD measurements in 3D printed, patient-specific 
phantoms. Our results show that using 3D printing to fabricate patient specific PMRT 
compensators is clinically feasible, and in many ways superior to conventional 3D based 
PMRT treatment planning. 
There are several advantages to using 3D printed compensators for PMRT treatments 
over conventional plans. Dosimetrically, our compensator based plans show improved target 
coverage with the prescription dose, and reduced hot spots throughout the patient volume. 
While slightly more of the ipsilateral lung receives low dose than in conventional plans, our 
compensator plans dramatically reduce the high dose coverage in the lung (Figure 5.2) 
because there are no tangent fields passing through the lung volume. Additionally, while the 
heart dose is elevated, the difference is not statistically significant and the doses are below all 
plan constraints for all cases. One dosimetric disadvantage of using these compensators is the 
elevated skin dose relative to conventional plans, which is not always desirable. This can be 
reduced by increasing the distance between the compensator and the skin, but this also 
negatively affects most other dose metrics. 
Beyond dosimetric considerations, compensator plans are easier to set up and align 
than conventional multi-field plans due to the fact that there is only one field and one energy. 
With further testing the true extent of time saving will be elucidated, but in our experience 
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we were able to set up and deliver a plan to a phantom on average every 15 minutes 
compared to the standard 30 minutes scheduled for PMRT patients at our clinic currently.  
Another important aspect of this study was the use of 3D printed phantoms to validate 
dose calculations using complex, 3D printed, patient-specific compensators. These phantoms 
allowed us to accurately reflect the complex anatomy that exists in PMRT treatments, and to 
fully validate the accuracy of our treatment plans. Specifically, our film errors (1.99mm), in-
field TLD errors (2.3%), and skin TLD errors (2.9%) all showed high agreement with TPS 
calculations. Our out-of-field TLD agreed within 16.9%±9%, which is acceptable uncertainty 
compared to other treatment planning systems and disease sites for out-of-field dose59, 60. 
While many advantages exist for 3D printed compensators, there are also some 
disadvantages to our system. 3D printing is relatively inexpensive and straightforward, but 
does require some level of expertise and investment in resources. Additionally, much care 
must be taken to make sure that the unique composition of 3D printed materials is accounted 
for with density corrections in the TPS, because as described in Chapter 3, most standard 
materials, including PLA, do not fall on the standard CT calibration curve52.  
Another consideration is that not all patients can be adequately treated using this 
technique. For one of the patients in our study we were unable to meet our ipsilateral lung 
dose constraints due to the extreme thinness of the chest wall, and the large curvature of the 
full target area. For this patient the use of bolus in conjunction with the compensator could 
have improved the dose distribution, but to keep the comparison with other patients identical 
this was not attempted. It is important to note, however, that using compensators may not be 
possible for all PMRT patients. However, the general methodology and underlying principles 
of our algorithm could be easily adapted to multiple other superficial treatment sites such as 
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the head and neck, scalp, and extremities, potentially opening up 3D printed based 
compensator treatments to a much larger population of patients.  
 
V.   CONCLUSION  
Our results show the clinical feasibility of using patient specific 3D printed compensators for 
PMRT. Specifically, we were able to demonstrate statistically significant improved CTV 
coverage and reduced hot spots, as well as a simplified planning and delivery. Additionally, 
we found that we could accurately calculate dose in our TPS using custom compensators, 
with all in-field TLD errors less than 3%. Additional work must be done to establish a clear 
patient workflow and QA procedure, but our results prove that 3D printed compensators are a 
clinically acceptable option for PMRT. 
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Chapter 6: Discussion 
I. PROJECT OVERVIEW  
The purpose of this work was to develop and validate a methodology to deliver 
postmastectomy radiation therapy (PMRT) without the currently existing difficulties 
associated with conventional 3D planning. This was accomplished in part by utilizing the 
unique capabilities of 3D printing technology to rapidly and inexpensively produce custom, 
patient-specific compensators. To fulfill this purpose, we started in Aim 1 by characterizing a 
variety of 3D printable materials and 3D printers to establish their suitability for radiation 
therapy. In Aim 2 we used our results from Aim 1 to design and produce a set of patient-
specific PMRT phantoms that could be used to test our new technique. In Aim 3 we 
developed an algorithm to design patient-specific compensators, and tested its clinical 
feasibility by comparing conventional and compensator based plans for a sample of PMRT 
patients. Finally, in Aim 4 we used the phantoms from Aim 2 and the algorithm from Aim 3 
to validate dose distributions for compensator based PMRT treatment plans. 
 Specific Aim 1 was to fully characterize 3D printable materials and 3D printing 
processes so that we could accurately and safely use 3D printing technology for radiation 
therapy applications. For four different commonly used materials—polylactic acid (PLA), 
acrylonitrile butadiene styrene (ABS), NinjaFlex, and Cheetah—we evaluated print accuracy, 
material density, average HU, print cost, print time, and application specific parameters like 
comfort and rigidity. Additionally, we measured percent depth dose (PDD) curves for 
NinjaFlex and PLA on two different linear accelerators (Varian 2100 and Varian TrueBeam) 
for the full range of clinical photon and electron energies available at our clinic. Measured 
PDDs were compared with TPS calculated PDDs to determine the accuracy of calculating 
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dose in 3D printed materials. We discovered from this analysis that there is a wide range in 
reproducibility between different materials, and that large variations in fundamental material 
properties like density exist even between objects printed under seemingly identical 
conditions. We additionally found that, generally speaking, the HU of a 3D printed object 
does not accurately predict the density of that object when using standard CT calibration 
curves. The relationship between density and HU is linear for most plastics, but it is not 
characterized accurately in treatment planning systems. However, we found that by 
measuring the density of each specific object, as well as checking its internal structure via CT 
imaging, these potential material concerns could be overcome and accurate dose calculations 
performed. While a number of other groups have investigated some material properties as 
part of their 3D printing research20, 23, 24, 31, 44, 45, 61, we believe that we were the first52 to fully 
characterize the potential dosimetric consequences of common 3D printable materials like 
NinjaFlex and PLA, and to provide specific quality assurance recommendations to avoid 
mistakes induced by material uncertainties. 
 In Specific Aim 2 we used the results from Specific Aim 1 to select PLA as a suitable 
plastic for producing patient-specific compensators and patient-specific phantoms. Next, 
using a group of consecutively sampled PMRT patients with a body mass index (BMI) range 
representative of our clinic’s PMRT patient population, we designed and 3D printed 6 
patient-specific phantoms. For each phantom, patient CT images were first converted into 3D 
models. Then, using several pieces of 3D modeling software, each patient model was 
sagittaly sliced into 2.5 cm thick slices, and trimmed to be 3D printable. Each phantom 
extends from the neck to approximately the naval, with the arms and head removed, but the 
shoulders left in place as much as possible to accurately reflect patient positioning. The final 
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modeled slices were all 3D printed, and the resultant phantoms were compared with their 
original CT data set as well as their planned models. Several other groups have previously 
printed phantoms for a variety of purposes, including special imaging tests26, 28, dose 
algorithm verification32, IMRT QA27, 48, clinical training29, 30, and many others25, 50, 62, 63. 
However, all of these phantoms were limited in size due to a combination of 1) the limited 
availability of large scale 3D printers, and 2) material warping considerations when printing 
solid objects. Some groups have gotten around these size limitations by printing phantoms in 
much smaller pieces, or printing molds28, 30, 62, 64, but this requires much more user effort and 
phantom assembly. Our 3D printed phantoms are unique, because we were able to overcome 
these size considerations and print full-scale phantoms43. This is largely due to our finding 
that sagittal slices print much more reliably than axial slices, and any material errors that do 
occur tend to happen on the bottom of the model where they do not interfere with the overall 
fit of the slices.  
 For Aim 3 we first developed an algorithm capable of calculating compensator 
models in RayStation (RaySearch Laboratories, Stockholm, Sweden), a research version of 
the commercial TPS in use at our clinic. The model was designed to create an initial thin 
compensator shape inside the electron tray, and then calculate the dose distribution in the 
patient. Based on this initial dose distribution, the compensator shapes were modified to 
account for excessively hot or cold spots in the CTV, and then the dose is recalculated in the 
patient. At this point the user can evaluate the dose distribution and either approve it or have 
the algorithm continue iterating the compensator shape. Once approved, the compensator 
shape is exported and prepared for 3D printing. We tested the algorithm using the same 
populations of 8PMRT patients from which the 6 patient-specific phantoms were designed. 
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For each patient we compared the dose distribution from a compensator plan with their 
original standard of care dose distribution, and tested individual metrics for significance with 
Bonferroni corrected paired t-tests. We found that relative to the standard 3D plans, 
compensator plans had statistically significant improvements in CTV dose coverage, CTV 
dose homogeneity, and hot spot reduction in the lungs. We also found that there were not 
significant differences in average lung or heart dose between the plan types. 
 Aim 4 was to validate and ensure the accuracy of the dose distributions calculated in 
Aim 3. To achieve this we first designed a simple wedge shaped compensator to fit in a 10 
cm × 10 cm electron tray, and used it to irradiate sheets of film using 12 MeV, 16 MeV, and 
20 MeV electron beams. We then compared the measured dose profiles with dose profiles 
calculated in RayStation. We found that we could accurately calculate the shape of the dose 
profile within 2 mm for all measured energies. Next we used the 6 patient specific phantoms 
created in Aim 2, and the algorithm created in Aim 3, to design and print 6 compensators. 
We delivered the compensator plan to each phantom, and recorded TLD doses in the skin, 
CTV, heart, and contralateral breast. Our TLD results were within 3% of planned doses for 
all TLD in the treatment area, and were within reasonable uncertainty levels for the out-of-
field TLD59, 60. This finding shows that we are able to accurately calculate dose distributions 
in compensator plans, and when using 3D printed materials.  
 
II. PROJECT LIMITATIONS 
 One limitation of using 3D printed materials for radiation oncology is the material 
variations. We found in our initial material analysis that PLA blocks printed in identical 
conditions on the same printer and using the same roll of filament can vary in density from 
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1.13 g/cm3 to 1.21 g/cm3, with an average of 1.18 g/cm3. For some materials, like Cheetah 
and ABS, these variations were considerably smaller, but variations in NinjaFlex were even 
larger than in PLA. There are additional variations to consider when using a different printer 
or material manufacturer. When identical blocks of PLA were printed using an identical, but 
different roll of filament from the same manufacturer as the first roll on an identical, but 
different 3D printer from the same manufacturer as the first printer, we observed a similar 
range and mean density in blocks. However, when those same blocks models were printed 
using a different model of 3D printer using PLA from a different manufacturer, we observed 
a mean density of 1.06 g/cm3, which is a greater than 10% difference in density. The two 
main concerns with these variations are that 1) any specific material analysis results from one 
clinic cannot be translated directly to another clinic because different printers and printer 
settings dramatically change material properties, and 2) even after commissioning a 3D 
printer a clinic must carefully examine every printed object to determine its specific 
correction factors because density can never be assumed. Fortunately, we have shown in this 
research that when printers and materials are carefully commissioned they can be used safely, 
and while our results cannot be translated to different clinics, our methodology as described 
in Chapter 3 and Appendix B can be translated and used elsewhere. 
 Another limitation of 3D printed materials is that there are limited types available, 
and they are generally not tissue equivalent. Of the various materials examined in this study, 
none of them could be considered to be radiologically water equivalent. One of the key 
findings of our material analysis was that CT calibration curves for treatment planning 
systems do not accurately predict the density of 3D printed objects. Even if one material 
could be found that is entirely equivalent to some specific tissue type, humans are made up of 
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a variety of tissues with varying densities and HU levels, ranging from the nearly air 
equivalent lungs, to bones and possibly even metal implants. The phantoms we printed were 
homogenous in all the bony and soft tissue areas of the body, which is by necessity a 
simplification somewhere (see Table 4.2). Even dual-material phantoms, which we have 
previously shown to be generally inferior in several characteristics45, 48, 65-67, are necessarily 
simplifying everything but one soft-tissue density and one bone density. However, even 
conventionally fabricated radiation oncology and imaging phantoms are made up of a 
discrete number of materials which don’t entirely accurately represent human tissue, not just 
3D printed ones. For our purposes, and likely many other use cases, the advantage of being 
able to easily create patient-specific anatomical shapes was more important than being able 
to exactly model interior tissue composition. 
 The elevated skin dose we observed in the compensator plans relative to patients’ 
conventional plans is another limitation of this study. The average dose to the skin in our 
sample’s conventional plans was 81.5% of the prescription dose. For the compensator plans, 
there was a statistically significant increase to 104.46% of the prescription dose. The 
maximum dose (D2%) in the skin was similarly increased for the compensator plans from 
115.45% to 124.18% of the prescribed dose; however, this difference was not statistically 
significant (Table 5.2). Skin reactions are one of the most common side effects of breast and 
chest wall irradiation, and can be debilitating68-70. Furthermore, skin reactions are directly 
correlated with dose71, 72. For some patients it is desirable to escalate skin dose in order to 
irradiate all potential microscopic disease and reduce the risk of chest wall recurrences68, and 
this is traditionally  accomplished by using bolus in conjunction with conventional treatment 
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planning. However, skin dose escalation is not uniformly used and if compensators are to be 
used regularly, the skin dose will already be elevated and so all potential skin sparing is lost.  
 
III. FUTURE DIRECTIONS 
 While the primary objective of this project was accomplished, there are several 
related questions left to be explored. These questions tend to fit into three main categories: 1) 
additional 3D printing material and technology research, 2) continuation and perfection of 
PMRT compensator development, and 3) additional treatment sites and opportunities for 
patient-specific devices. 
 
A. 3D Printing and Technology Research 
 Mentioned as a limitation earlier in this chapter, it has been well established that 3D 
printing materials have highly variable material properties, and that they are not tissue 
equivalent. However, this work has detailed research into only four materials, and one type 
of 3D printing technology. While FDM printing is the least expensive and most accessible 
type of 3D printing, many more expensive options exist that may provide more reliable or 
tissue-equivalent material, and there are dozens of available materials for FDM that we have 
not tested. An interesting and open question is if any of these other myriad options would be 
superior in quality than our findings. In general, continuing to characterize new materials and 
3D printers should be a priority to take full advantage of the potential applications of 3D 
printing.  
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B. Clinical Implementation of 3D Printed PMRT Compensators 
In order for 3D printed PMRT compensators to be readily adopted in the clinic there 
are several steps that first must be taken. First of all, the compensator design algorithm 
detailed in Chapter 5 must be made to be more user-friendly, and much faster. The algorithm 
as currently written (Appendix E) uses ROI addition and subtraction to determine the 
position of the anterior and posterior surfaces of the compensator, CTV, and prescription 
isodose line. This is a time consuming calculation, and is performed along each ray line 
several times as the check ROI progresses along the line because these positions are not 
known a priori. A better calculation would determine the proximity of the check ROI to each 
of these points with a single calculation, thus reducing calculation time by more than an order 
of magnitude. Another time limitation is that several steps of the algorithm currently require 
user input. Steps like assigning the gantry angle, setting the SSD, and checking to see if plan 
constraints have been met could theoretically be automated in the future. Additionally, the 
algorithm is currently implemented in RayStation 5.99, but the newest version, RayStation 7, 
allows for direct STL export of ROIs. Updating the algorithm to be used in RayStation 7 
could make it possible to avoid using any other software.  
As part of the algorithm process we had to commission a new machine with shortened 
electron applicators. This was because RayStation does not allow ROI volumes to intersect 
the area of the electron applicator, and the compensators are designed to fit in the electron 
tray with the cerrobend poured around them. To get around this we commissioned a new 
TrueBeam  machine with shortened electron applicators, and we design the cerrobend tray as 
part of the algorithm. Our TLD and film results have shown that this process can be used to 
accurately calculate dose. However, this machine is only commissioned for research use. It 
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would have to be commissioned for clinical use, or a new build of RayStation tested and 
approved for clinical use that allows ROIs in the electron tray before PMRT compensators 
can be clinically used.  
Another difficulty of this process is the preparation of the compensator in the tray and 
the actual clinical implementation. Generally the treatment planning system prepares a 
template for electron blocks that make it simple to pour the cerrobend in the right place, but 
because our machine’s electron applicators are shortened this rendering is incorrect. To align 
the compensator in the electron tray we rendered the cerrobend ROI on a grid, captured a 
screenshot of that, and printed it to scale on several pieces of paper. We then taped the pieces 
of paper together, and aligned the grid with the electron tray. This process worked, but was 
time consuming and is potentially sensitive to human error. There is no reason this could not 
also be automated as part of the script to produce the same document as is produced for other 
electron plans to simplify compensator placement in the tray. Once the compensator is in the 
tray, making sure that patients are aligned with the tray is also important. For our phantoms 
we used external fiducials and known shifts, and then checked that against our expected SSD. 
This is not always possible with patients, and some form of image guided alignment will 
likely be necessary. This needs to be developed and implemented. 
A final question regarding clinical implementation of PMRT compensators is 
deciding which patients are eligible for it. Will all patients be planned with conventional 3D 
plans, and then only poor cases be referred for compensators? This adds much time and 
reduces the simplicity advantage that compensators and the algorithm provide. Or perhaps all 
patients will initially be planned with compensators and poor cases will be referred to 3D 
planning? Again, this is a potential waste of time and resources if it could be known ahead of 
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time which patients would benefit most from which treatment type. It seems likely that some 
criteria, such as thickness and curvature of chest well, depth of CTV, or skin surface 
complexity, could be used to determine the optimal treatment modality for patients before 
planning so that each type of plan can be taken full advantage of. 
 
C. Additional Treatment Sites and Devices 
 Separate from PMRT, there are several other disease sites that could be treated using 
3D printed patient-specific compensators. Additionally, there are several other 3D printable 
patient-specific devices that could be used to improve radiation therapy. One example of this 
is making surface based patient-specific compensators. We explored this possibility some, 
and have detailed those experiments in Appendix C, but there is much work left to be done, 
including adapting the algorithm to fit compensators on the skin, and validating dose 
measurements. Additional improvements into printing with NinjaFlex, which we used, or 
finding a different material suitable for surface based treatments, would also be required. 
 Another interesting potential use of these PMRT compensators is to not treat the 
whole volume of CTV with one electron compensator, and instead use the compensator to 
just combine multiple IMC fields. Most of the chest wall would still be treated with photon 
tangents, but the IMC would be treated with a 3D printed compensator. The IMC fields 
would be reduced from multiple non-conformal fields to a single conformal field. This 
adaptation would be more similar to current treatment techniques, while still providing 
clinical value. Additionally, IMC specific compensators would be smaller, making them 
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much easier to design, faster to print, and less expensive than compensators covering the full 
CTV. 
 Patient-specific compensators could also be used in a variety of treatment sites other 
than the chest wall. Previously, Su et al.20 have demonstrated the utility of 3D printing a 
compensator for a pediatric rhabdomyosarcoma case, showing a mean reduction in dose to 
the left kidney of 38.2% relative to conventional bolus. Zhao et al.33 have 3D printed patient-
specific comepensators for a number of disease sites, including a squamous cell carcinoma of 
the nasal septum, a basal cell carcinoma of the posterior pinna, and a mycosis fungoides 
involving the upper face. 3D printing has also been used by Zou et al.23 to treat superficial 
cancer around the ear, and previously our group has reported the use of a 3D printed neck 
bolus for total body irradiation73. However, in all of these cases the bolus was designed to be 
conformal to the skin, and not in the electron tray. If these sites could be treated using 
compensators of our design that fit into the electron tray, they could perhaps be further 
simplified and improved.  
 
IV. CONCLUSIONS 
In this work we developed a new methodology to design patient-specific 
compensators for PMRT that fit in the electron tray rather than the surface of the patient. We 
additionally validated this methodology using 3D printed, patient-specific phantoms loaded 
with TLD. Our results show that patient-specific compensators can be used to significantly 
improve and simplify radiation therapy for postmastectomy patients. Specifically, we have 
demonstrated improvements in CTV coverage, CTV homogeneity, and reduction in hot spots 
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in the lungs. Average skin dose was also significantly increased for the compensator plans, 
but changes in hot spots in the skin were insignificant. Additionally, we have shown that it is 
possible to fabricate these compensators using 3D printing technology, and that we can 
accurately calculate dose distributions using 3D printed compensators and patient-specific 
phantoms, despite potentially large variations in the material properties of 3D printed objects. 
These results show that with proper quality assurance and testing, 3D printing technology can 
be used to fabricate patient-specific compensators that can improve dose distributions in 
patients receiving postmastectomy radiation therapy.  
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Appendix A: Patient Dose Data 
Patient 1 
Table A.1: Patient 1 Dose and Planning Data 
Metric Conventional Plan Compensator Plan 
Nominal Electron Energy (MeV) NA 12 
Gantry Angle NA 29.2 
SSD (cm) NA 99 
MU/fx NA 195 
CTV D98 (cGy) 4103 4400 
CTV Average Dose (cGy) 5299 5087 
CTV D2 (cGy) 6781 5899 
CTV V45 (%) 88.78 95.1 
Heart Average Dose (cGy) 240 360 
Heart V30 (%) 0 0.22 
Ipsilateral Lung Average Dose (cGy) 1634 1685 
Ipsilateral Lung D2 (cGy) 5587 3894 
Ipsilateral Lung V20 (%) 32.52 39.86 
Ipsilateral Lung V40 (%) 13.95 0.84 
Total Lung Average Dose (cGy) 918 862 
110% Hotspot Volume (cm3) 333.52 49.76 
130% Hotspot Volume (cm3) 24.69 0 
150% Hotspot Volume (cm3) 0 0 
Skin Average Dose (cGy/Gy) 75.66 100.8 
Skin D2 (cGy/Gy) 120.18 115.6 
CTV Heterogeneity Index 53.56 29.98 
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Figure A.1: Patient 1 3D and compensator plan DVH. 
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Figure A.2: Axial slice of Patient 1 3D and compensator plan dose distributions. The 110%, 
90% (prescription), 70%, and 50% isodose lines are shown as green, yellow, blue, and white 
colorwash, respectively. For comparison, the conventional plan 90% and 110% isodose lines 
are shown as red and purple lines, respectively. The CTV is also shown in light blue. 
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Patient 2 
Table A.2: Patient 2 Dose and Planning Data 
Metric Conventional Plan Compensator Plan 
Nominal Electron Energy (MeV) NA 9 
Gantry Angle NA 22.0 
SSD (cm) NA 99 
MU/fx NA 234 
CTV D98 (cGy) 3959 4450 
CTV Average Dose (cGy) 5302 5470 
CTV D2 (cGy) 6609 6717 
CTV V45 (%) 92.82 97.26 
Heart Average Dose (cGy) 234 376 
Heart V30 (%) 0 0.37 
Ipsilateral Lung Average Dose (cGy) 1380 1605 
Ipsilateral Lung D2 (cGy) 5208 3848 
Ipsilateral Lung V20 (%) 26.73 38.06 
Ipsilateral Lung V40 (%) 10.89 0.76 
Total Lung Average Dose (cGy) 696 841 
110% Hotspot Volume (cm3) 160.21 139.09 
130% Hotspot Volume (cm3) 8.42 13.48 
150% Hotspot Volume (cm3) 0 0 
Skin Average Dose (cGy/Gy) 103.9 115.26 
Skin D2 (cGy/Gy) 130.06 139.02 
CTV Heterogeneity Index 53 45.34 
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Figure A.3: Patient 2 3D and compensator plan DVH. 
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Figure A.4: Axial slice of Patient 2 3D and compensator plan dose distributions. The 110%, 
90% (prescription), 70%, and 50% isodose lines are shown as green, yellow, blue, and white 
colorwash, respectively. For comparison, the conventional plan 90% and 110% isodose lines 
are shown as red and purple lines, respectively. The CTV is also shown in light blue. 
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Patient 3 
Table A.3: Patient 3 Dose and Planning Data 
Metric Conventional Plan Compensator Plan 
Nominal Electron Energy (MeV) NA 9 
Gantry Angle NA 25.8 
SSD (cm) NA 99 
MU/fx NA 219 
CTV D98 (cGy) 3946 4450 
CTV Average Dose (cGy) 5302 5497 
CTV D2 (cGy) 6818 6510 
CTV V45 (%) 88.98 97.56 
Heart Average Dose (cGy) 242 139 
Heart V30 (%) 0.04 0 
Ipsilateral Lung Average Dose (cGy) 1673 1101 
Ipsilateral Lung D2 (cGy) 5184 3678 
Ipsilateral Lung V20 (%) 34.24 26.21 
Ipsilateral Lung V40 (%) 16.45 0.38 
Total Lung Average Dose (cGy) 792 549 
110% Hotspot Volume (cm3) 228.6 206.18 
130% Hotspot Volume (cm3) 20.67 4.75 
150% Hotspot Volume (cm3) 1.56 0 
Skin Average Dose (cGy/Gy) 71.12 111.82 
Skin D2 (cGy/Gy) 112.98 129.42 
CTV Heterogeneity Index 57.44 41.2 
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Figure A.5: Patient 3 3D and compensator plan DVH. 
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Figure A.6: Axial slice of Patient 3 3D and compensator plan dose distributions. The 110%, 
90% (prescription), 70%, and 50% isodose lines are shown as green, yellow, blue, and white 
colorwash, respectively. For comparison, the conventional plan 90% and 110% isodose lines 
are shown as red and purple lines, respectively. The CTV is also shown in light blue. 
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Patient 4 
Table A.4: Patient 4 Dose and Planning Data 
Metric Conventional Plan Compensator Plan 
Nominal Electron Energy (MeV) NA 12 
Gantry Angle NA 31.9 
SSD (cm) NA 99 
MU/fx NA 208 
CTV D98 (cGy) 3520 4400 
CTV Average Dose (cGy) 4985 5230 
CTV D2 (cGy) 5883 6149 
CTV V45 (%) 83.69 96.2 
Heart Average Dose (cGy) 296 387 
Heart V30 (%) 0.04 0.35 
Ipsilateral Lung Average Dose (cGy) 1118 1400 
Ipsilateral Lung D2 (cGy) 4633 3678 
Ipsilateral Lung V20 (%) 22 32.17 
Ipsilateral Lung V40 (%) 6.85 0.28 
Total Lung Average Dose (cGy) 525 740 
110% Hotspot Volume (cm3) 93.81 180.64 
130% Hotspot Volume (cm3) 0.61 1.16 
150% Hotspot Volume (cm3) 0 0 
Skin Average Dose (cGy/Gy) 73.78 104.92 
Skin D2 (cGy/Gy) 98.58 120.46 
CTV Heterogeneity Index 47.26 34.98 
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Figure A.7: Patient 4 3D and compensator plan DVH. 
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Figure A.8: Axial slice of Patient 4 3D and compensator plan dose distributions. The 110%, 
90% (prescription), 70%, and 50% isodose lines are shown as green, yellow, blue, and white 
colorwash, respectively. For comparison, the conventional plan 90% and 110% isodose lines 
are shown as red and purple lines, respectively. The CTV is also shown in light blue. 
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Patient 5 
Table A.5: Patient 5 Dose and Planning Data 
Metric Conventional Plan Compensator Plan 
Nominal Electron Energy (MeV) NA 12 
Gantry Angle NA 23.0 
SSD (cm) NA 100 
MU/fx NA 206 
CTV D98 (cGy) 3440 4500 
CTV Average Dose (cGy) 4993 5119 
CTV D2 (cGy) 5899 6035 
CTV V45 (%) 82.21 98 
Heart Average Dose (cGy) 281 483 
Heart V30 (%) 0.01 1.39 
Ipsilateral Lung Average Dose (cGy) 1314 1581 
Ipsilateral Lung D2 (cGy) 4941 4259 
Ipsilateral Lung V20 (%) 27.16 34.94 
Ipsilateral Lung V40 (%) 11.25 6.08 
Total Lung Average Dose (cGy) 574 753 
110% Hotspot Volume (cm3) 71.16 66.75 
130% Hotspot Volume (cm3) 0.77 0.5 
150% Hotspot Volume (cm3) 0 0 
Skin Average Dose (cGy/Gy) 66.16 100.78 
Skin D2 (cGy/Gy 100.94 117.64 
CTV Heterogeneity Index 49.18 30.7 
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Figure A.9: Patient 5 3D and compensator plan DVH. 
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Figure A.10: Axial slice of Patient 5 3D and compensator plan dose distributions. The 
110%, 90% (prescription), 70%, and 50% isodose lines are shown as green, yellow, blue, and 
white colorwash, respectively. For comparison, the conventional plan 90% and 110% isodose 
lines are shown as red and purple lines, respectively. The CTV is also shown in light blue. 
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Patient 6 
Table A.6: Patient 6 Dose and Planning Data 
Metric Conventional Plan Compensator Plan 
Nominal Electron Energy (MeV) NA 12 
Gantry Angle NA 18.9 
SSD (cm) NA 99.5 
MU/fx NA 225 
CTV D98 (cGy) 4226 4500 
CTV Average Dose (cGy) 5549 5579 
CTV D2 (cGy) 8515 6568 
CTV V45 (%) 94.68 98 
Heart Average Dose (cGy) 409 185 
Heart V30 (%) 0 0 
Ipsilateral Lung Average Dose (cGy) 1991 1527 
Ipsilateral Lung D2 (cGy) 5837 3800 
Ipsilateral Lung V20 (%) 39.6 35.77 
Ipsilateral Lung V40 (%) 19.63 0.51 
Total Lung Average Dose (cGy) 1017 818 
110% Hotspot Volume (cm3) 825.35 473.78 
130% Hotspot Volume (cm3) 163.97 16.47 
150% Hotspot Volume (cm3) 56.73 0 
Skin Average Dose (cGy/Gy) 81.14 93.72 
Skin D2 (cGy/Gy) 121.96 130.1 
CTV Heterogeneity Index 85.78 41.36 
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Figure A.11: Patient 6 3D and compensator plan DVH. 
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Figure A.12: Axial slice of Patient 6 3D and compensator plan dose distributions. The 
110%, 90% (prescription), 70%, and 50% isodose lines are shown as green, yellow, blue, and 
white colorwash, respectively. For comparison, the conventional plan 90% and 110% isodose 
lines are shown as red and purple lines, respectively. The CTV is also shown in light blue. 
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Patient 7 
Table A.7: Patient 7 Dose and Planning Data 
Metric Conventional Plan Compensator Plan 
Nominal Electron Energy (MeV) NA 9 
Gantry Angle NA 22.5 
SSD (cm) NA 99.25 
MU/fx NA 224 
CTV D98 (cGy) 4369 4500 
CTV Average Dose (cGy) 5396 5548 
CTV D2 (cGy) 7282 6557 
CTV V45 (%) 95.92 98 
Heart Average Dose (cGy) 250 118 
Heart V30 (%) 0 0.01 
Ipsilateral Lung Average Dose (cGy) 1554 1053 
Ipsilateral Lung D2 (cGy) 5140 3929 
Ipsilateral Lung V20 (%) 32.13 24.47 
Ipsilateral Lung V40 (%) 13.47 1.48 
Total Lung Average Dose (cGy) 692 485 
110% Hotspot Volume (cm3) 219.46 227.93 
130% Hotspot Volume (cm3) 38.36 7.24 
150% Hotspot Volume (cm3) 2.83 0 
Skin Average Dose (cGy/Gy) 101.38 110.68 
Skin D2 (cGy/Gy) 133.78 130.66 
CTV Heterogeneity Index 58.26 41.14 
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Figure A.13: Patient 7 3D and compensator plan DVH. 
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Figure A.14: Axial slice of Patient 7 3D and compensator plan dose distributions. The 
110%, 90% (prescription), 70%, and 50% isodose lines are shown as green, yellow, blue, and 
white colorwash, respectively. For comparison, the conventional plan 90% and 110% isodose 
lines are shown as red and purple lines, respectively. The CTV is also shown in light blue. 
104 
 
Patient 8 
Table A.8: Patient 8 Dose and Planning Data 
Metric Conventional Plan Compensator Plan 
Nominal Electron Energy (MeV) NA 12 
Gantry Angle NA 29.4 
SSD (cm) NA 99 
MU/fx NA 190 
CTV D98 (cGy) 3644 4450 
CTV Average Dose (cGy) 5022 4913 
CTV D2 (cGy) 5964 5574 
CTV V45 (%) 85.49 96.5 
Heart Average Dose (cGy) 288 320 
Heart V30 (%) 0 0.11 
Ipsilateral Lung Average Dose (cGy) 1540 1813 
Ipsilateral Lung D2 (cGy) 5145 4092 
Ipsilateral Lung V20 (%) 30.73 42.93 
Ipsilateral Lung V40 (%) 14.02 3.15 
Total Lung Average Dose (cGy) 767 1030 
110% Hotspot Volume (cm3) 123.57 14.12 
130% Hotspot Volume (cm3) 2.35 0 
150% Hotspot Volume (cm3) 0 0 
Skin Average Dose (cGy/Gy) 79.34 97.7 
Skin D2 (cGy/Gy) 105.14 110.56 
CTV Heterogeneity Index 46.4 22.48 
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Figure A.15: Patient 8 3D and compensator plan DVH. 
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Figure A.16: Axial slice of Patient 8 3D and compensator plan dose distributions. The 
110%, 90% (prescription), 70%, and 50% isodose lines are shown as green, yellow, blue, and 
white colorwash, respectively. For comparison, the conventional plan 90% and 110% isodose 
lines are shown as red and purple lines, respectively. The CTV is also shown in light blue. 
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Appendix B: 3D Printing Material Analysis Procedure 
When commissioning a new material for 3D printing it is important to consider several 
factors, including print accuracy, print consistency, material density, material HU, material 
stopping power, and other application-specific needs. The following guide describes a way to 
ensure material properties are well understood before use. Our overall procedure is to a) 
evaluate the material’s overall suitability, b)determine the print consistency and accuracy of 
an object, c)measure CT based metrics, and d)measure percent depth doses. 
 
I.  MATERIAL OVERVIEW 
When a new material is first obtained the user should attempt to print several simple 
objects, like blocks, cylinders, or simple geometric shapes. After iterating several attempts, a 
“best practice” can be determined. The best printing practice can vary significantly between 
materials, and includes things like bed temperature, nozzle temperature, print speed, infill 
percentage, infill pattern, flow rate, and more. These factors can strongly affect the internal 
material properties of a printed object, so once they are decided it is important to keep them 
consistent unless you also want to retest the material. 
At this point it is also appropriate to evaluate the overall quality of the material for its 
intended purpose. If it is intended to be used in patient contact, is it comfortable? If it is 
going to be used to hold things, is it rigid and strong? If it will be used often, does it print 
well, or does the printer need lots of “babying” with it? These questions should be addressed 
before continuing.  
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II. MATERIAL PRINTING CHARACTERISTICS 
Once a material’s overall suitability has been considered it is important to consider 
printing accuracy. For this step the user will define and print a sample of at least 5 simple 
objects, preferably cubes or boxes on a similar scale to objects the material is intended for. 
The 5 objects should be compared for print consistency, and evaluated for density and print 
accuracy. When determining material density the dimensions should be measured to 
determine volume, not assumed to be accurate from the intended model. Print accuracy can 
be defined in 2 main ways: physical accuracy and CT based accuracy. 
1) Physical Accuracy: 
Physical measurement metrics of print accuracy are determined by measuring the actual 
dimensions of printed objects with accurate calipers and comparing with the dimensions of 
the intended model. These metrics should include the directionality of measurement for 
linear metrics. For example, if an object is 1 mm larger than intended, it is important to know 
if that is in the plane parallel with the printing bed or perpendicular to the printing bed. Also, 
it is generally more useful to report these errors in absolute scale (mm), rather than in percent 
difference, because the scale of errors for most materials is similar regardless of object size. 
Physical measurement accuracy can also be reported as a volume, where percent error is 
more meaningful because it correlates to overall density. 
2) CT Based Accuracy: 
Sometimes CT based measurements are more useful. For example, if the intended object 
is a patient-specific device modeled in a treatment planning system, it is important that the 
CT based rendering of the device be similar to the intended model. For CT based metrics, the 
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object should be CT imaged using standard protocols, and then the resulting image should be 
converted to a 3D file format in the same way the original model would be designed. Several 
software options exist for this including blender, Osirix, Slicer, and others. The resulting 
printed object model can then be compared with the intended object model. As with 
measured errors, these errors can be reported as linear dimensions, or volumetrically. 
 
III. CT BASED METRICS 
If a material is not going to be used in a radiation environment, the remaining steps are 
unnecessary. If an object’s radiological properties are of interest, a CT of the blocks used to 
determine print accuracy is the first step. Each of the 5 blocks should be contoured in the CT 
exam, with the exact protocol determined by the material’s intended use. If, for example, the 
entire object will be used, a threshold based contouring technique may be valuable. If known 
print errors exist in the bottom centimeter or so of an object and that area won’t be in-beam, 
perhaps leaving it out of the contour is more appropriate. Whatever contouring technique is 
used, it should be consistently applied. 
Once contoured, the average HU and standard deviation should be measured for each 
block. Additionally, the CT should be visually examined to make sure there aren’t regions in 
the blocks with holes or print inconsistencies.  
The average HU of each block should be plotted against its measured density, and 
compared with the standard CT calibration curve for that CT scanner. This is a vital step to 
take, to make sure that materials are behaving as you would predict. If necessary, this may 
indicate to the user of any specific QA practices that need to be employed. 
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IV. PERCENT DEPTH DOSE MEASUREMENTS 
If a material is going to be used in the beam path as a treatment related device, it is 
important to measure the percent depth dose of various clinical beams in that material. This is 
important, because it allows the user to guarantee that radiation interacts with the material in 
the way that the treatment planning system predicts. To determine this with certainty there 
are three steps. First, measurements are taken in the material, second, material specific 
correction factors are applied to determine PDD, and third, measured PDDs are compared 
with PDDs modeled in that material by the TPS. 
The PDD measurement can be taken several ways, but again should be consistent once 
established. Our technique is described here. First, 5 material blocks are printed. Object A 
has dimensions of 20 cm by 20 cm by 2.5 cm. Object B and C are both 5 cm by 20 cm by 2.5 
cm. Object D is 5 mm by 20 cm by 2.5 cm, and object E is 3 mm by 20 cm by 2.5 cm. 
Objects A, B, and C have holes in them for ion chamber placement. The width of the hole 
depends on the ion chamber being used. Our blocks are designed with a 6 mm A1SL in mind. 
Renderings of these objects are shown in Figure B.1. 
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Figure B.1: The 5 PDD measurement blocks. Part A has a single hole placed for 5 cm of 
material above and beneath, Part B has a hole for 1 cm above, and 4 cm beneath, and part C 
has a hole for 2 cm above, and 3 cm beneath. Parts D and E have no holes. All ion chamber 
holes extend 10 cm deep into the middle of the block. 
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These blocks can be stacked in various orders with an ion chamber placed in one of 
the holes to achieve a large range of measurement depths. For example, B-C-A can be used 
for 1 cm deep. C-B-A can be used for 2 cm. For 3 cm, use “upside down C”-B-A. For 
smaller resolution, employ blocks D and E as needed. One irradiation position is shown in 
Figure B.2. For all measurement points we place solid water sheets on either side of the 
printed blocks, and we take 3 measurements at each point of at least 100 MU each. All beam 
energies that an object might be used in should have PDD measurements done.  
Determining the PDD for photons is a simple matter of dividing each data point by 
the highest data point, but for electrons some manual corrections need to be applied. To 
determine the actual PDD for electron beams we follow the protocol outlined in TG 25. The 
Prepl. error correction is taken from tables in TG 25
46, and the material specific stopping 
power ratio correction factors are taken from NIST’s online modeling software ESTAR47. 
To model the material in the TPS and compare PDDs, a CT should be taken of the 
PDD blocks with solid water around them. That CT can then be used to create a simple AP 
plan like was used to perform the PDD measurements. Calculate what the TPS thinks the 
PDD in that material should be, and compare that with what was actually measured. For 
some materials, the density for the material may need to be manually overridden in order to 
get good agreement, as was likely noticed while measuring CT based metrics in Section III 
(also see Chapter 3). 
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Figure B.2: Percent depth dose measurement set-up. In this photograph, the ion chamber was 
inserted into the top hole at the 1-cm depth position. Holes not occupied by the ion chamber 
were plugged with acrylic rods to avoid air gaps. Solid water (brown) sheets were positioned 
on either side of the NinjaFlex to ensure scatter equilibrium.  
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V. CONCLUSION 
Once a material has been shown to fit the application specific needs, can be printed 
accurately and consistently, and can be accurately modeled in the TPS, you are ready to go. It 
is important to remember that any new material, new printer, or even a dramatically different 
new use case my require repeating most or all of the steps listed above. Never assume that a 
3D printed objects precise material properties can be known without being examined, and 
remember that internal defects may not be obvious even after measuring the density, so a CT 
is almost always necessary. With these rules and guidelines in mind, 3D printing can be safe, 
and very productive in radiation therapy. 
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Appendix C: Surface Compensator Studies 
I. INTRODUCTION 
In the previously unpublished study described below, we explored the option of 
designing and using 3D printed compensators that fit on the patient’s skin instead of in the 
electron tray. These compensators were designed to be made out of NinjaFlex, a flexible and 
soft material that would be more comfortable for patients rather than the relatively more rigid 
PLA that has been described earlier. In the end the decision was made not to pursue surface 
based compensators for several reasons: NinjaFlex is more difficult to print with than PLA, 
NinjaFlex is more expensive than PLA, NinjaFlex takes much longer to print than PLA, 
surface based compensators can be harder to align and keep in place than rigid ones, and 
finally because there were concerns regarding the skin dose from using a surface 
compensator for each patient. Regardless of these limitations, the methods, results, and a 
brief conclusion of the research performed regarding 3D printed, soft, surface compensators 
is described below. 
 
     II.       METHODS AND MATERIALS 
A. Basic Material Analysis 
We printed 5 cm × 5 cm × 5 cm cubic blocks of the flexible thermoplastic NinjaFlex 
(NinjaTek, Manheim, PA). NinjaFlex cubes were printed on an FDM style Gigabot 2.0 
printer (re3D, Houston, TX) using a 0.40 mm nozzle, 100% infill, 0.20 mm layer height, and 
0.8 mm wall thickness.  
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We tested NinjaFlex for print accuracy, physical density, and Hounsfield units (HU). 
We also evaluated the print speed and cost.  Print accuracy was defined as the largest 
absolute Euclidean distance discrepancy between the designed and printed object, as 
measured by sub-millimeter resolution calipers. We also used these measured dimensions 
and the measured mass of the blocks to determine the physical density of the printed 
material. Material cost and print speed were determined by the actual price paid for the 
material, and printer settings were taken directly from the recommendations of the material 
manufacturing companies. 
A computed tomography (CT) image was acquired for each block on a Philips 
Brilliance Big Bore (Philips Healthcare, Andover, Massachusetts) and the average HU was 
measured from that image. We contoured each block with a 2-mm buffer from the edge and 
determined the average HU and its standard deviation. For comparison, we assessed the 
average chest wall HU for a group of five clinical PMRT patients at our institution. As part 
of an Institutional Review Board–approved protocol, the patients were selected consecutively 
from a population of patients treated by the American Board of Radiology (ABR)–certified 
collaborating radiation oncologist (WW) between 12/1/2014 and 12/1/2015. The patients are 
representative of the body mass index range in our clinic.     
To evaluate the flexibility and printability of the NinjaFlex material, we printed a 
large compensator for an anthropomorphic phantom. This simple compensator was designed 
to make the entire surface of the chest flat with respect to an anterior beam.   
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B.  Percent Depth Dose Measurements 
To perform percent depth dose (PDD) measurements we printed several much larger 
blocks of NinjaFlex. One 20 cm × 20 cm × 2.5 cm block and two 20 cm × 5 cm × 2.5 cm 
blocks were printed of each of the two materials. When stacked, the printed blocks of each 
material formed a sheet 30 cm tall, 20 cm long, and 2.5 cm wide. One 5 mm × 2.5 cm × 20 
cm block and one 3 mm × 2.5 cm × 20 cm was also printed for each of the two materials. At 
our in-house machine shop, holes were drilled in each of the three larger blocks to 
accommodate a small volume ion chamber, the Exradin A1SL (Standard Imaging Inc., 
Middleton, WI). The holes within the blocks were drilled such that with various stacking 
orders the ion chamber could be positioned a depths of 1 to 11 cm at 1-cm increments. By 
adding the 5-mm or 3-mm strips on top of the other blocks, 0.3-cm measurement increments 
were possible.  
For each depth, we took three measurements with a calibrated (National Institute of 
Standards and Technology (NIST) traceable) A1SL ion chamber for each electron and 
photon energy available in our clinic.  All measurements were performed on two Varian 
2100 linear accelerators (Varian Medical Systems, Palo Alto, CA) for 6- and 18-MV photon 
energies and 4, 6, 7, 9, 11, 12, 16, and 20 MeV electrons. Note that, for all measurements, 
solid water sheets were positioned on either side of the printed blocks to ensure scatter 
equilibrium. Holes not occupied by the ion chamber were plugged with acrylic rods to avoid 
air gaps. All measurements were performed with a 100-cm source-to-surface distance (SSD) 
and using a 10 cm × 10 cm electron applicator.  
For each ion chamber reading, the dose was calculated by following the protocol in 
the American Association of Physicists in Medicine Task Group 25 report46. Because the 
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precise chemical make-up of NinjaFlex is not known and because the density is very close to 
water, water-to-air stopping power ratios were used.  Then, a PDD curve was calculated for 
each beam energy by normalizing the dose at each depth to the maximum dose. 
 
C. Comparison of Measured and Calculated Percent Depth Doses 
To ensure the capacity of the treatment planning system to accurately calculate dose 
within NinjaFlex, a CT image was acquired of the blocks using the same set-up configuration 
that was used to measure PDD (Section III.B). For this work, all calculations were performed 
using a commercial treatment planning system, Pinnacle3 V9.10 (Philips Healthcare, 
Andover, Massachusetts).  This is the primary planning system at our institution for photon 
and electron dose calculations and is fully commissioned for clinical use.  A single-field 
treatment plan was created at every available electron and photon energy for the blocks of 
NinjaFlex. NinjaFlex seemed to be correctly modeled, so the sole input to the treatment 
planning system for each treatment plan was the acquired CT of the set-up conditions used in 
Section III.B to measure PDD (i.e., 100 cm SSD, 10 cm × 10 cm electron applicator for 
electron beams). The calculated dose corresponding to each measurement point was recorded 
for all plans and then a PDD curve was calculated by normalizing the dose at each depth to 
the maximum dose. 
 
D. Compensator Design and Fabrication  
We designed a PMRT compensator from the CT scan of the anthropomorphic 
phantom. The collaborating radiation oncologist (WW), who specializes in breast radiation 
oncology, delineated a clinical target volume (CTV) on the phantom CT that was 
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representative of a typical PMRT CTV, including the internal mammary chain (IMC) vessels 
levels I-III and the chest wall. 
We used a simple ray-tracing method to design a compensator that achieved a 
uniform antero-posterior thickness of 5 cm from the compensator surface to the distal edge of 
the contoured CTV. This thickness was chosen because it corresponds closely with the 90% 
depth dose of our 16 MeV electron beam and was sufficiently deep so there weren’t any 
holes in the compensator design. We used the ATOM male dosimetry anthropomorphic 
phantom (CIRS Tissue Simulation and Phantom Technology, Norfolk, VA) for which the 
arm position could not be adjusted, resulting in a CTV that was much deeper than would be 
observed in an actual patient whose arm would be raised out of the treatment area, allowing 
the use of a shallower depth and therefore thinner compensator. Nonetheless, for a proof of 
principle study this methodology was reasonable, and works well for delineating the surface 
of the phantom. 
The compensator design was converted to the standard tessellation language (.STL) 
file format that most 3D printers use by using OsiriX software (Pixmeo; Bernex, 
Switzerland). The 3D printing software Simplify3D (Cincinnati, OH) was then used to 
generate machine code (commonly referred to as g code) which provides the 3D printer with 
a series of commands for printing the compensator and a variety of support structures around 
it to ensure print accuracy. The g code was transferred to the Gigabot 2.0 printer, and the 
compensator was printed with the flexible NinjaFlex filament. The compensator was printed 
with its inferior border on the printing bed, because this arrangement minimizes warping. 
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E. Compensator Validation 
To ensure the capacity of the treatment planning system to accurately calculate dose 
with a NinjaFlex compensator in place and to validate the accuracy of our complex 3D-
printed compensator, we created and delivered a simple single-electron field PMRT plan. 
The printed compensator was placed on the anthropomorphic phantom, and a CT image was 
acquired. A 16 MeV single-field electron PMRT plan was created by an ABR–certified 
clinical medical physicist (RMH) whose specialty is breast radiation therapy. The plan was 
reviewed and approved by the radiation oncologist (WW). The treatment was delivered 
according to the plan using a clinical Varian 2100 to the anthropomorphic phantom with the 
compensator in place.    
Thermoluminescent dosimeters (TLD) were placed throughout the phantom during 
irradiation. The TLD were read by following the methodology described by Kirby et al.58.  
Measured TLD doses were then compared with doses predicted by the treatment planning 
system to assess the consistency of the compensator planning and placement. 
 
F. Compensator Plan Comparison 
We next compared the compensator plan with two current standard-of-care PMRT 
techniques used at our institution. The additional treatment plans were calculated for the 
phantom by a certified medical dosimetrist (JK) whose specialty is breast radiation therapy. 
Specifically, we considered two conventional radiation therapy planning techniques that are 
routinely used in our clinic, photon tangents with an electron IMC field and a three-field 
electron technique. The first comparison plan used a mixed photon/electron technique with 
electron IMC fields split (because of differing CTV depths) into an 11 MeV upper portion 
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and a 7 MeV lower portion matched to two tangential photon fields that were mixed 6- and 
18-MV energies with field-in-field modulation. The three-field electron technique consisted 
of electron fields covering the IMC split into a 9 MeV upper portion and a 6 MeV lower 
portion, a 4 MeV medial chest wall electron field, and a 9 MeV lateral chest wall electron 
field. The prescription was 50 Gy to the chest well and IMC. The beam design for the two 
comparison treatment plans are shown in Figure C.1, along with the single-field electron 
compensator plan. 
 
Figure C.1: 3D skin rendering showing the treatment fields for the standard-of-care and 
compensator plans: (a) The photon/electron plan, (b) the three-field electron plan, and (c) the 
single-field 16 MeV electron compensator plan. 
 
The treatment plans were evaluated by various metrics such as mean chest wall and 
IMC doses, chest wall and IMC volumes receiving 90% of the prescribed dose (V90), and 
dose to 2% of the chest wall and IMC.  Additionally, isodose curves were evaluated for CTV 
a. b. c.
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coverage as well as for presence of hot and cold spots throughout the treatment area, in 
particular at the field junctions for the standard-of-care plans.   
 
     III.      RESULTS 
A. Basic Material Analysis 
  The basic properties of the materials studied and patient sample are listed in Table 
C.1. 
 
Table C.1: Physical and radiological properties of a range of 3D printable plastics compared 
to a sample of PMRT patient chest walls. 
Material 
Mean 
HU±1SD 
Physical Density 
(g/cm
3
) 
Print 
Error 
(mm) 
Print 
Speed 
Material 
Cost 
Patient chest 
wall tissue -32±67 
water/muscle:1.00,  
fat: 0.92a 
   
N/A N/A N/A 
NinjaFlex -107±21 1.04 
 
0.09 25 mm/s $87/kg 
aPhysical densities for water/muscle and fat were taken from the literature74 
 
NinjaFlex was identified as a viable material based on physical density, HU similar to 
soft tissue, and low print error. The NinjaFlex material additionally is flexible and thus, we 
anticipate, more conformable to irregular PMRT surfaces.  Because compensators for PMRT 
must be conformable to highly irregular surfaces, a flexible material is better suited for 
PMRT than a rigid material.  Also, a property that is not well represented by the table or 
figure but is nonetheless important in material selection is that the NinjaFlex is “softer” to the 
touch and thus would be more comfortable when placed on a patient’s skin.   
123 
 
 
B. Comparison of Measured and Calculated Percent Depth Doses 
The calculated PDD curves (solid lines) are shown next to the corresponding 
measured curves (triangles) in NinjaFlex in Figure C.2. Measurements in NinjaFlex agreed 
with calculated curves within 2 mm for all electron energies, except for 20 MeV where 
differences up to 4 mm were observed. Measurements in 6- and 18-MV photon beams agreed 
within 2%. 
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Figure C.2: PDD curves in NinjaFlex are shown as calculated in the treatment planning 
system (solid lines) and as measured (triangles). (a) shows calculated and measured curves in 
NinjaFlex for low-energy electron beams (4, 6, 7, and 9 MeV), (b) shows  measured and 
calculated PDDs for high-energy electron beams (11, 12, 16, and 20 MeV), and (c) show 6- 
and 18-MV photon beams. 
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C. Compensator Design and Fabrication  
We printed a flexible NinjaFlex compensator with maximum dimensions of 22 × 21 × 
15 cm with negligible (< 1 mm) material warping based on comparing measurable design 
dimensions. The printing took ~70 hours and cost less than $75 in material. The compensator 
bends easily but completely restores its shape when pressure is removed. 
 
D. Compensator Validation 
The printed compensator fit well on the phantom, with no air gaps greater than 2 mm 
as measured by CT. Figure C.3 shows the compensator on the phantom, as well as the 16 
MeV single-field electron plan. The compensator had an average HU of -115±13, which is 
very similar to the measured block (Table C.1). The compensator is overall very 
homogenous, with some small heterogeneities visible. The TLD measurements agreed well 
with doses predicted by the treatment planning system. TLD placed within the CTV agreed 
with predicted doses within 5%, and more distal TLD located in the lung and heart agreed 
within 12%.  
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Figure C.3: The 3D printed compensator plan in the (a) sagittal plane and (d) axial plane 
with triangles indicating positions of TLD during irradiation. (b) is a photograph of the 
compensator on the anthropomorphic phantom during irradiation. The CTV is shown as 
shaded contours: IMC levels I-III and chest wall are red. The heart is shown in shaded 
purple. The 45 Gy (90%) isodose line is shown as a thick yellow line. (c) and (e) show 
similar planes as (a) and (d), but without the treatment plan obscuring the homogeneity of the 
printed compensator or its fit on the phantom. 
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E. Compensator Plan Comparison 
The three treatment plans were compared for mean chest wall and IMC doses, chest 
wall and IMC volumes receiving 90% of the prescribed dose, dose to 2% of the chest wall 
and IMC, and presence of hot and cold spots throughout the treatment area. These results are 
summarized in Table C.2. 
 
 
 
Table C.2: Summary of various dose metrics for the three treatment plan techniques 
compared in this study. For all plans, the prescribed dose to the IMC and chest wall (CW) 
CTV was 50 Gy.  The Dmean is the mean dose in Gy to the volume.  The V90 is the percent 
volume receiving 90 percent of the prescribed dose. D2 is the dose in Gy to 2% of the 
volume. 
Dose Metric 
Photon/Electron 
Plan 3-Field Electron Plan 
Single-field 
Electron 
Compensator Plan 
CW Dmean±1SD 
(Gy) 50.87±4.79 45.16±10.82 46.79±5.88 
IMC Dmean±1SD 
(Gy) 53.74±2.46 49.10±2.14 49.44 ±3.68 
CW V90 (%) 89.8 60.1 70.5 
IMC V90 (%) 99.4 96.9 89.0 
CW D2 (Gy) 57.65 66.15 56.95 
IMC D2 (Gy) 59.55 54.70 56.25 
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The photon/electron and three-field electron plans both yielded larger and more 
extreme hot and cold spots than the compensator plan. The compensator plan had one hot 
spot that reached up to 114% of the prescribed dose in the area of the phantom’s left arm. 
The photon/electron plan showed hot spots at the junction between the IMC fields and at the 
junction between the IMC and medial to lateral tangent. These hot spots exceeded 120% of 
the prescribed dose. The three-field electron plan had the most hot spots, with 120% hot 
spots at the junctions between the IMC, medial, and lateral fields, as well as between the 
upper and lower IMC fields. One hot spot between the medial and lateral fields exceeded 
130% of the prescribed dose. Additionally, the three-field electron plan had cold spots 
adjacent to each hot spot. These hot and cold spots can be seen in Figure C.4, which shows 
representative axial and sagittal views of each treatment plan (same views shown for all 
plans). 
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Figure C.4: Comparison of the isodose distributions from the three treatment plans evaluated 
in this study. The CTV is contoured in shaded red, while the 45 Gy (90%) isodose line is 
shown in thick yellow. Hot spots of 120% and 110 % are illustrated by magenta and blue 
isodose lines, respectively. The photon/electron plan is shown in (a) axial and (b) sagittal 
views; the three-field electron plan in (c) axial and (d) sagittal views; and the single-field 
compensator plan in (e) axial and (f) sagittal views. Note the greater presence of hot spots in 
both the three-field electron and photon/electron plans than in the single-field compensator 
plan. 
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IV. DISCUSSION 
In this study we demonstrated the feasibility of designing and 3D printing a full-scale, 
large PMRT compensator with flexible NinjaFlex material for an anthropomorphic phantom. 
Additionally, we compared a single-field electron compensator treatment plan with two 
standard-of-care plans and demonstrated that the single-field electron compensator plan is a 
suitable option for PMRT. Together, these findings demonstrate the clinical feasibility of 3D 
printed compensators for PMRT. 
 Previous studies applying 3D-printing technology to fabricate tissue compensators20, 
22-24 have considered only rigid printable materials. Here, we demonstrated that flexible 
materials can be used to 3D print large-volume compensators for a large anatomical site such 
as the chest wall in PMRT. We found that NinjaFlex approximates the properties of soft 
tissue well and is flexible, allowing for a more conformal and comfortable fit on the patient’s 
body surface. Despite being flexible, we found that NinjaFlex was relatively incompressible 
and restored its shape exactly even after being deformed many times. The PDD curves 
measured in NinjaFlex agreed very well with calculated PDDs. It also exhibited almost no 
material warping during printing. The main drawback of using NinjaFlex is the long print 
times; equivalent solids take about three times longer to print with NinjaFlex than with PLA 
or ABS. 
 Designing and printing a simple compensator to achieve uniform thickness to the 
distal edge of the desired CTV was straightforward. The print time of such a large object is, 
however, a current limitation of 3D printing. NinjaFlex requires particularly slow print 
speeds, so the compensator took nearly 70 hours to print. However, this limitation is likely to 
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lessen because of the precipitously increasing library of available printing materials and the 
rapid development of 3D printing technology.  
 A limitation of this study is that the method we used to design the compensator did 
not account for electron scatter, true SSD, or tissue heterogeneities in the phantom. Another 
limitation of our study is that we used an anthropomorphic phantom whose arm position 
necessitated that our compensator be designed for use with a 16 MeV electron beam in order 
to penetrate to the most distal part of the chest wall CTV. This high-energy beam caused a 
correspondingly higher heart and lung dose than we otherwise would have expected. 
Designing a compensator for a phantom analogous to a PMRT patient, i.e., ipsilateral arm 
raised, would allow use of lower energy and less-penetrating electrons, such as 9 or 12 MeV. 
This would have several beneficial dosimetric effects. First and most importantly, dose to the 
lungs and heart would be reduced.  Additionally, the overall thickness of the compensator 
would be substantially reduced, leading to a shorter print time and lower material costs.  
 
V. CONCLUSIONS  
In this study, we 3D printed an actual full-size PMRT compensator of flexible, tissue-
equivalent plastic and demonstrated that a single-field compensator plan with this 
compensator performed well compared to two standard-of-care treatment techniques. The 
compensator had an average HU of -115 ± 13, and calculated PDDs in the material agreed 
with measured values within 2 mm for all electron energies up to 20 MeV. TLD 
measurements from the delivered compensator plan agreed with planned doses within 5% 
within the CTV. The results of this study demonstrated that 3D printing can be used to 
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produce chest wall compensators that make simple, single-electron field plans a viable 
clinical option for PMRT. With continued material testing and improved compensator design 
algorithms, dose distributions will be improved for PMRT patients, and compensator use will 
be possible for a range of additional treatment sites. 
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Appendix D: Algorithm Use Instructions 
The algorithm as currently written (Appendix E) is designed to run as a 
semiautomatic script in RayStation version 6R (named 5.99 Proton in Citrix). This appendix 
serves as an informal instruction manual on using the algorithm and preparing a compensator 
to be 3D printed. 
First of all, there are a number of conditions that must be met in order for the 
algorithm to work as designed. 
Algorithm Conditions: 
1) Patient be left-sided 
2) Patient have External and CTV_eval contours defined 
3) Planning CT be named “CT 1” 
4) Have an existing plan open in RayStation 
5) Don’t have any plans named “comp plan”, or any ROIs named “Compensator” or “e-
cutout” 
a. Alternately, if you just want to modify a compensator but not create the plan 
from scratch, make sure you have all of the above items, as well as a 
calculated dose distribution. 
If these conditions are met, you can start the algorithm by navigating to its file 
location in the scripting interface and pressing play. Shortly after you will get a message that 
looks like this: 
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At this point move to the “plan design” tab and select the newly created “comp plan,” 
then navigate to the “Electron Beam Design” tab. Rotate the gantry angle of the beam in 
order to create the most evenly en face angle possible. Next open the “T&P Settings” menu, 
mark the check box for “Apply margin settings to all beams,” and but 2.5 into the Y2 box. It 
should look like the screen shot below. 
  
Under “Settings” make sure the number of monte carlo histories is at least 10,000, 
and press OK. Finally set the SSD to skin to be 100 cm, then press “conform all beams.” 
Now navigate back to the scripting menu, and press the play button to resume the script. Now 
the script will create an ROI representing the electron cerrobend cutout as well as the 
compensator, which can take a few minutes. 
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When the initial ROI shapes of the electron cut out and compensator are completed a 
pop up box like this will show up. 
 
Open the ROIs tab on the left, and double click on Compensator. In the ROI 
properties menu under “Material,” select PLA, then press OK. Next select the ROI 
“e_cutout” and set its material to cerrobend. Both of those ROIs should now have a star next 
to them, and look like this in the list. Once that is done, press play again in the scripting tab. 
 
 
Next the script will calculate the dose distribution in the patient. At this point you can 
examine the shape of the dose distribution yourself, and see if any parts of the compensator 
can be thickened or thinned out a lot to start out with. Be very careful to not over do things, 
but it can save a lot of time by reducing iterations if you manually modify the shape of the 
compensator now to give it a bit of a best guess to start with. When you are satisfied, click 
OK on the pop up message warning you this is the last step, and then press play again on the 
scripting menu. 
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This is now the iterative part of the algorithm. The script will run through the whole 
compensator and determine which sections need to be made thicker and which sections need 
to be made thinner. Once that has been determined it will alter the shape of the compensator 
accordingly, and then recalculate dose. Then the script is finished and closes. The user then 
examines the dose distribution in the patient as well as any relevant dose metrics. If desired, 
the user may also modify the shape of the compensator ROI if again it is obvious that it needs 
to be much thicker or thinner is some place. If any adjustments are made make sure to 
recalculate dose before continuing. If the user is unsatisfied with the dose distribution, reopen 
the script and play it again. It will start at the point of modulating the compensator shape as 
long as it detects a Compensator ROI already exists. Once you are satisfied with the plan and 
compensator, export the DICOM data. You don’t need to export the plan and dose, but you 
need the CT and the ROI structure sets. 
Next open 3D Slicer. Press the purple button in the top left that says DCM, then 
import and load the DICOM of the patient that was just exported. Under modules open  
“Segmentations.” On the right hand side open the export/import tab, select models, and press 
export. It should look like this. 
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Now click on the “Save” button on the top left with the red arrow. Deselect 
everything except the Compensator ROI, set its file format to be .STL, choose the directory 
you want the file to go, and press save. Open the saved .STL file in Simplify3D, and set all 
the settings to below. 
 
Finally, press “Prepare to Print,” save the .gcode file to an SD card, put it in the 3D 
printer, and print the compensator. 
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Appendix E: Algorithm Code 
 This is the unabridged IronPython code for the RayStation script that designs the 
compensators. As much as possible it has been commented to explain what is going on. 
##This Python code can be used to calculate compensator shapes for left sided PMRT 
patients, BUT IS NOT CLINICALLY APPROVED. DO NOT USE THIS CODE FOR 
CLINICAL APPLICATIONS. 
 
from connect import * 
import math 
import copy 
 
############################ 
#This first function creates the compensator plan and beam set, as well as the first 
compensator shape 
 
def comp_init(): 
 
 case = get_current("Case") 
 examination = get_current("Examination") 
 
 with CompositeAction('Add Treatment plan'): 
 
   newplan = case.AddNewPlan(PlanName="comp plan", PlannedBy="", Comment="", 
ExaminationName=examination.Name, AllowDuplicateNames=False) 
 
   newplan.SetDefaultDoseGrid(VoxelSize={ 'x': 0.3, 'y': 0.3, 'z': 0.3 }) 
 
   beam_set = newplan.AddNewBeamSet(Name="comp plan", ExaminationName="CT 1", 
MachineName="TBModApplicators", Modality="Electrons", 
TreatmentTechnique="ApplicatorAndCutout", PatientPosition="HeadFirstSupine", 
NumberOfFractions=25, CreateSetupBeams=True, 
UseLocalizationPointAsSetupIsocenter=False, Comment="", RbeModelReference=None, 
EnableDynamicTrackingForVero=False) 
 
   beam_set.AddDosePrescriptionToRoi(RoiName="CTV_eval", DoseVolume=0, 
PrescriptionType="NearMinimumDose", DoseValue=4500, RelativePrescriptionLevel=1, 
AutoScaleDose=True) 
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   # CompositeAction ends  
 
 #now we need to calculate the isocenter first pass guess 
 structure_set=newplan.GetStructureSet() 
 ctv_cent=structure_set.RoiGeometries["CTV_eval"].GetCenterOfRoi() 
 iso_position = {'x':ctv_cent.x, 'y':ctv_cent.y, 'z':ctv_cent.z} 
 electron_energy=12 
  
 with CompositeAction('Add beam (electron beam, Beam Set: comp plan)'): 
  
   newbeam = beam_set.CreateElectronBeam(ApplicatorName="Varian 25x25 85 end", 
Energy=electron_energy, InsertName="cutout1", IsAddCutoutChecked=True, 
IsocenterData={ 'Position': iso_position, 'NameOfIsocenterToRef': "", 'Name': "comp plan 
1", 'Color': "98, 184, 234" }, Name="electron beam", Description="", GantryAngle=0, 
CouchAngle=0, CollimatorAngle=0) 
  
   newbeam.SetBolus(BolusName="") 
  
 await_user_input('Change gantry angle as appropriate, move the isocenter, set the SSD to 
100, and set monte carlo histories.') 
 
 #now we read the gantry angle to use in the shift calculations 
 gantry_angle_deg=beam_set.Beams['electron beam'].GantryAngle 
 gantry_angle=gantry_angle_deg*math.pi/180 
 
 #now we add the compensator 
 plan = get_current("Plan") 
 #here is where we form the first guess of what the compensator will look like, imbedded into 
the electron insert 
 
 comp_guess2(case, examination, beam_set) 
 
 #now we set the comp ROI properties. Note that the materials setting isn't a particular 
material, but where it falls on the list. this seems like a problem 
 with CompositeAction('Apply ROI changes (compv1)'): 
 
   case.PatientModel.RegionsOfInterest['Compensator'].Type = "Fixation" 
 
   case.PatientModel.RegionsOfInterest['Compensator'].OrganData.OrganType = "Other" 
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 await_user_input('Set the Compensator ROI material to be PLA, and the electron cutout to 
cerrobend.') 
 
   # CompositeAction ends  
 #for now we aren't computing dose because the applicator won't let it work anyway  
 beam_set.ComputeDose(ComputeBeamDoses=True, 
DoseAlgorithm="ElectronMonteCarlo", ForceRecompute=False) 
 
################################ 
 
#this comp guess is the one that creates the compensator and electron cutout with the comp in 
the insert 
def comp_guess2(case, examination, beam_set):  
     
    #both the e_cutout and compensator ROIs are labelled as Fixation, but material 
designation must be done manually by the user 
 
    spot = beam_set.Beams['electron beam'].Isocenter.Position 
 
    with CompositeAction('Create Box ROI (electron_cutout)'): 
 
        retval_0 = case.PatientModel.CreateRoi(Name="electron_cutout", Color="Magenta", 
Type="Fixation", TissueName=None, RoiMaterial=None) 
 
        retval_0.CreateBoxGeometry(Size={ 'x': 25, 'y': 2, 'z': 25 }, Examination=examination, 
Center={ 'x': 0, 'y': 0, 'z': spot.z }) 
 
        # CompositeAction ends  
 
    ssd = 100 
    comp_shift = ssd-96.25 
 
    gantry_angle_deg=beam_set.Beams['electron beam'].GantryAngle 
    gantry_angle=gantry_angle_deg*math.pi/180 
 
    rotate_mat = {'M11':math.cos(gantry_angle), 'M12':-math.sin(gantry_angle), 'M13':0, 
'M14':spot.x+comp_shift*math.sin(gantry_angle), 
                            'M21':math.sin(gantry_angle), 'M22':math.cos(gantry_angle), 'M23':0, 
'M24':spot.y-comp_shift*math.cos(gantry_angle), 
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                            'M31':0, 'M32':0, 'M33':1, 'M34':0, 
                            'M41':0, 'M42':0, 'M43':0, 'M44':1} 
    
case.PatientModel.RegionsOfInterest["electron_cutout"].TransformROI3D(Examination=exa
mination, TransformationMatrix=rotate_mat) 
 
 
    #now we need to delete out a cavity for the CTV 
 
    with CompositeAction('Expand (CTV)'): 
 
        retval_0 = case.PatientModel.CreateRoi(Name="CTV_copy", Color="SaddleBrown", 
Type="Organ", TissueName=None, RoiMaterial=None) 
 
        retval_0.CreateMarginGeometry(Examination=examination, 
SourceRoiName="CTV_eval", MarginSettings={ 'Type': "Expand", 'Superior': .5, 'Inferior': 
0.5, 'Anterior': 0.5, 'Posterior': 0.5, 'Right': 0.5, 'Left': 0.5 }) 
 
        # CompositeAction ends  
    with CompositeAction('Expand (CTV)'): 
 
        retval_1 = case.PatientModel.CreateRoi(Name="CTV_copy2", Color="SaddleBrown", 
Type="Organ", TissueName=None, RoiMaterial=None) 
 
        retval_1.CreateMarginGeometry(Examination=examination, 
SourceRoiName="CTV_eval", MarginSettings={ 'Type': "Expand", 'Superior': .4, 'Inferior': 
0.4, 'Anterior': 0.4, 'Posterior': 0.4, 'Right': 0.4, 'Left': 0.4 }) 
    with CompositeAction('Expand (CTV_copy2)'): 
 
        
case.PatientModel.RegionsOfInterest['CTV_copy2'].CreateMarginGeometry(Examination=e
xamination, SourceRoiName="CTV_copy2", MarginSettings={ 'Type': "Expand", 'Superior': 
2, 'Inferior': 2, 'Anterior': 2, 'Posterior': 2, 'Right': 2, 'Left': 2 }) 
 
        # CompositeAction ends  
 
 
    with CompositeAction('Contract (CTV_copy2)'): 
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case.PatientModel.RegionsOfInterest['CTV_copy2'].CreateMarginGeometry(Examination=e
xamination, SourceRoiName="CTV_copy2", MarginSettings={ 'Type': "Contract", 
'Superior': 2, 'Inferior': 2, 'Anterior': 2, 'Posterior': 2, 'Right': 2, 'Left': 2 }) 
 
  # CompositeAction ends  
    # CompositeAction ends  
    yshift = -.5*math.cos(gantry_angle) 
    xshift = .5*math.sin(gantry_angle) 
 
    shift_mat = {'M11':1, 'M12':0, 'M13':0, 'M14':xshift, 
                            'M21':0, 'M22':1, 'M23':0, 'M24':yshift, 
                            'M31':0, 'M32':0, 'M33':1, 'M34':0, 
                            'M41':0, 'M42':0, 'M43':0, 'M44':1} 
    for n in range(0,20): 
 
    #now we expand ctv_copy into electron cutout. We will repeat this step after each shift. 
 
        with CompositeAction('ROI Algebra (Compensator)'): 
 
            
case.PatientModel.RegionsOfInterest['CTV_copy2'].CreateAlgebraGeometry(Examination=e
xamination, Algorithm="Auto", ExpressionA={ 'Operation': "Union", 'SourceRoiNames': 
["CTV_copy2"], 'MarginSettings': { 'Type': "Expand", 'Superior': 0, 'Inferior': 0, 'Anterior': 0, 
'Posterior': 0, 'Right': 0, 'Left': 0 } }, ExpressionB={ 'Operation': "Union", 'SourceRoiNames': 
["CTV_copy"], 'MarginSettings': { 'Type': "Expand", 'Superior': 0, 'Inferior': 0, 'Anterior': 0, 
'Posterior': 0, 'Right': 0, 'Left': 0 } }, ResultOperation="Union", ResultMarginSettings={ 
'Type': "Expand", 'Superior': 0, 'Inferior': 0, 'Anterior': 0, 'Posterior': 0, 'Right': 0, 'Left': 0 }) 
 
        #with CompositeAction('ROI Algebra (electron_cutout)'): 
            
#case.PatientModel.RegionsOfInterest['electron_cutout'].CreateAlgebraGeometry(Examinati
on=examination, Algorithm="Auto", ExpressionA={ 'Operation': "Union", 
'SourceRoiNames': ["electron_cutout"], 'MarginSettings': { 'Type': "Expand", 'Superior': 0, 
'Inferior': 0, 'Anterior': 0, 'Posterior': 0, 'Right': 0, 'Left': 0 } }, ExpressionB={ 'Operation': 
"Union", 'SourceRoiNames': ["CTV_copy"], 'MarginSettings': { 'Type': "Expand", 'Superior': 
0, 'Inferior': 0, 'Anterior': 0, 'Posterior': 0, 'Right': 0, 'Left': 0 } }, 
ResultOperation="Subtraction", ResultMarginSettings={ 'Type': "Expand", 'Superior': 0, 
'Inferior': 0, 'Anterior': 0, 'Posterior': 0, 'Right': 0, 'Left': 0 }) 
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case.PatientModel.RegionsOfInterest["CTV_copy"].TransformROI3D(Examination=examin
ation, TransformationMatrix=shift_mat) 
        # CompositeAction ends  
 
 
    with CompositeAction('Delete ROI (CTV_copy)'): 
 
        retval_0.DeleteRoi() 
 
        # CompositeAction ends  
 
    with CompositeAction('ROI Algebra (cutoutregion)'): 
 
        retval_0 = case.PatientModel.CreateRoi(Name="cutoutregion", Color="Orange", 
Type="Organ", TissueName=None, RoiMaterial=None) 
 
        retval_0.SetAlgebraExpression(ExpressionA={ 'Operation': "Intersection", 
'SourceRoiNames': ["electron_cutout", "CTV_copy2"], 'MarginSettings': { 'Type': "Expand", 
'Superior': 0, 'Inferior': 0, 'Anterior': 0, 'Posterior': 0, 'Right': 0, 'Left': 0 } }, ExpressionB={ 
'Operation': "Union", 'SourceRoiNames': [], 'MarginSettings': { 'Type': "Expand", 'Superior': 
0, 'Inferior': 0, 'Anterior': 0, 'Posterior': 0, 'Right': 0, 'Left': 0 } }, ResultOperation="None", 
ResultMarginSettings={ 'Type': "Expand", 'Superior': 0, 'Inferior': 0, 'Anterior': 0, 'Posterior': 
0, 'Right': 0, 'Left': 0 }) 
 
        retval_0.UpdateDerivedGeometry(Examination=examination, Algorithm="Auto") 
 
        # CompositeAction ends  
 
    with CompositeAction('Delete ROI (CTV_copy2)'): 
 
            case.PatientModel.RegionsOfInterest['CTV_copy2'].DeleteRoi() 
 
        # CompositeAction ends  
 
    with CompositeAction('ROI Algebra (e_cutout)'): 
 
        retval_1 = case.PatientModel.CreateRoi(Name="e_cutout", Color="Blue", 
Type="Fixation", TissueName=None, RoiMaterial=None) 
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        retval_1.SetAlgebraExpression(ExpressionA={ 'Operation': "Union", 
'SourceRoiNames': ["electron_cutout"], 'MarginSettings': { 'Type': "Expand", 'Superior': 0, 
'Inferior': 0, 'Anterior': 0, 'Posterior': 0, 'Right': 0, 'Left': 0 } }, ExpressionB={ 'Operation': 
"Union", 'SourceRoiNames': ["cutoutregion"], 'MarginSettings': { 'Type': "Expand", 
'Superior': 0, 'Inferior': 0, 'Anterior': 0, 'Posterior': 0, 'Right': 0, 'Left': 0 } }, 
ResultOperation="Subtraction", ResultMarginSettings={ 'Type': "Expand", 'Superior': 0, 
'Inferior': 0, 'Anterior': 0, 'Posterior': 0, 'Right': 0, 'Left': 0 }) 
 
        retval_1.UpdateDerivedGeometry(Examination=examination, Algorithm="Auto") 
 
        # CompositeAction ends  
 
    with CompositeAction('Delete ROI (electron_cutout)'): 
 
        case.PatientModel.RegionsOfInterest['electron_cutout'].DeleteRoi() 
 
        # CompositeAction ends  
 
    with CompositeAction('Contract (cutoutregion)'): 
 
        retval_2 = case.PatientModel.CreateRoi(Name="cutcutcut", Color="Blue", 
Type="Organ", TissueName=None, RoiMaterial=None) 
 
        retval_2.CreateMarginGeometry(Examination=examination, 
SourceRoiName="cutoutregion", MarginSettings={ 'Type': "Contract", 'Superior': 0.3, 
'Inferior': 0.3, 'Anterior': 0.3, 'Posterior': 0.3, 'Right': 0.3, 'Left': 0.3 }) 
 
        # CompositeAction ends  
 
    with CompositeAction('Apply ROI changes (cutoutregion)'): 
 
        case.PatientModel.RegionsOfInterest['cutoutregion'].Name = "Compensator" 
 
        case.PatientModel.RegionsOfInterest['Compensator'].Type = "Fixation" 
 
        case.PatientModel.RegionsOfInterest['Compensator'].OrganData.OrganType = "Other" 
 
        # CompositeAction ends  
 
    for n in range(0,2): 
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    #now we delete out from compensator. We will repeat this step after each shift. 
 
        with CompositeAction('ROI Algebra (Compensator)'): 
            
case.PatientModel.RegionsOfInterest['Compensator'].CreateAlgebraGeometry(Examination=
examination, Algorithm="Auto", ExpressionA={ 'Operation': "Union", 'SourceRoiNames': 
["Compensator"], 'MarginSettings': { 'Type': "Expand", 'Superior': 0, 'Inferior': 0, 'Anterior': 
0, 'Posterior': 0, 'Right': 0, 'Left': 0 } }, ExpressionB={ 'Operation': "Union", 
'SourceRoiNames': ["cutcutcut"], 'MarginSettings': { 'Type': "Expand", 'Superior': 0, 
'Inferior': 0, 'Anterior': 0, 'Posterior': 0, 'Right': 0, 'Left': 0 } }, 
ResultOperation="Subtraction", ResultMarginSettings={ 'Type': "Expand", 'Superior': 0, 
'Inferior': 0, 'Anterior': 0, 'Posterior': 0, 'Right': 0, 'Left': 0 }) 
        
case.PatientModel.RegionsOfInterest["cutcutcut"].TransformROI3D(Examination=examinati
on, TransformationMatrix=shift_mat) 
        # CompositeAction ends  
 
    with CompositeAction('Delete ROI (cutcutcut)'): 
 
        case.PatientModel.RegionsOfInterest['cutcutcut'].DeleteRoi() 
           
############################## 
#this first section creates the mover and mover2 ROIs and puts it at the initilization point, 
and also creates the addition and subtraction ROIs 
def create_mover(mover_position, case): 
    with CompositeAction('Create Sphere ROI (mover)'): 
        mover_ROI = case.PatientModel.CreateRoi(Name="mover", Color="Green", 
Type="Organ", TissueName=None, RoiMaterial=None) 
        #mover_ROI.CreateSphereGeometry(Radius=0.15, Examination=examination, 
Center={ 'x': mover_position[0], 'y': mover_position[1], 'z': mover_position[2] }) 
 
    with CompositeAction('Create Sphere ROI (mover2)'): 
        mover2_ROI = case.PatientModel.CreateRoi(Name="mover2", Color="Orange", 
Type="Organ", TissueName=None, RoiMaterial=None) 
        #mover2_ROI.CreateSphereGeometry(Radius=0.15, Examination=examination, 
Center={ 'x': mover_position[0], 'y': mover_position[1], 'z': mover_position[2] }) 
 
    with CompositeAction('Create Sphere ROI (addition)'): 
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        addition_ROI = case.PatientModel.CreateRoi(Name="addition", Color="Cyan", 
Type="Organ", TissueName=None, RoiMaterial=None) 
 
    with CompositeAction('Create Sphere ROI (subtraction)'): 
        subtraction_ROI = case.PatientModel.CreateRoi(Name="subtraction", Color="Orange", 
Type="Organ", TissueName=None, RoiMaterial=None) 
 
############################## 
#this returns 0 if we are not in Compensator, and returns 1 if we are in Compensator 
def check_mover_in_Compensator(case, plan): 
   
    position = 0 
 
    structure_set=plan.GetStructureSet() 
 
    with CompositeAction('ROI Algebra (mover)'): 
        
case.PatientModel.RegionsOfInterest['mover'].CreateAlgebraGeometry(Examination=exami
nation, Algorithm="Auto", ExpressionA={ 'Operation': "Union", 'SourceRoiNames': 
["mover"], 'MarginSettings': { 'Type': "Expand", 'Superior': 0, 'Inferior': 0, 'Anterior': 0, 
'Posterior': 0, 'Right': 0, 'Left': 0 } }, ExpressionB={ 'Operation': "Union", 'SourceRoiNames': 
["Compensator"], 'MarginSettings': { 'Type': "Expand", 'Superior': 0, 'Inferior': 0, 'Anterior': 
0, 'Posterior': 0, 'Right': 0, 'Left': 0 } }, ResultOperation="Subtraction", 
ResultMarginSettings={ 'Type': "Expand", 'Superior': 0, 'Inferior': 0, 'Anterior': 0, 'Posterior': 
0, 'Right': 0, 'Left': 0 }) 
     
    try: 
        vol = structure_set.RoiGeometries['mover'].GetRoiVolume() 
        if vol <.1: 
            position = 1 
    except: 
        position = 1 
    #wrods = str(vol)#this can be used to check the volume of the mover each time it steps if 
you are concerned there are problems 
    #await_user_input(wrods) 
    return position 
 
############################## 
#this returns 0 if we are not in compensator, and returns 1 if we are in compensator 
def check_mover2_in_comp(case, plan): 
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    position = 0 
 
    structure_set=plan.GetStructureSet() 
 
    with CompositeAction('ROI Algebra (mover2)'): 
        
case.PatientModel.RegionsOfInterest['mover2'].CreateAlgebraGeometry(Examination=exam
ination, Algorithm="Auto", ExpressionA={ 'Operation': "Union", 'SourceRoiNames': 
["mover2"], 'MarginSettings': { 'Type': "Expand", 'Superior': 0, 'Inferior': 0, 'Anterior': 0, 
'Posterior': 0, 'Right': 0, 'Left': 0 } }, ExpressionB={ 'Operation': "Union", 'SourceRoiNames': 
["Compensator"], 'MarginSettings': { 'Type': "Expand", 'Superior': 0, 'Inferior': 0, 'Anterior': 
0, 'Posterior': 0, 'Right': 0, 'Left': 0 } }, ResultOperation="Subtraction", 
ResultMarginSettings={ 'Type': "Expand", 'Superior': 0, 'Inferior': 0, 'Anterior': 0, 'Posterior': 
0, 'Right': 0, 'Left': 0 }) 
     
    try: 
        vol = structure_set.RoiGeometries['mover2'].GetRoiVolume() 
        if vol <.014: 
            position = 1 
    except: 
        position = 1 
 
    return position 
 
############################# 
#this returns 2 of we are in CTV_eval, and returns 1 if we are partially out of CTV  IT IS 
SUPER IMPORTANT THAT THIS IS THE OPPOSITE OF THE CHECK THAT THE 
OTHER ONE DOES 
def check_mover_in_CTV(case, plan, mover_position, CTV_count1, structure_set): 
    #the position=0 if not in vtest, 1 if in vtest 
    position = 2 
 
    with CompositeAction('ROI Algebra (mover)'): 
        
case.PatientModel.RegionsOfInterest['mover'].CreateAlgebraGeometry(Examination=exami
nation, Algorithm="Auto", ExpressionA={ 'Operation': "Union", 'SourceRoiNames': 
["mover"], 'MarginSettings': { 'Type': "Expand", 'Superior': 0, 'Inferior': 0, 'Anterior': 0, 
'Posterior': 0, 'Right': 0, 'Left': 0 } }, ExpressionB={ 'Operation': "Union", 'SourceRoiNames': 
["CTV_eval"], 'MarginSettings': { 'Type': "Expand", 'Superior': 0, 'Inferior': 0, 'Anterior': 0, 
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'Posterior': 0, 'Right': 0, 'Left': 0 } }, ResultOperation="Subtraction", ResultMarginSettings={ 
'Type': "Expand", 'Superior': 0, 'Inferior': 0, 'Anterior': 0, 'Posterior': 0, 'Right': 0, 'Left': 0 }) 
    vol = 0 
    try: 
        vol = structure_set.RoiGeometries['mover'].GetRoiVolume() 
        if vol > .01: 
            position = 1 
    except: 
        position = 2 
 
    if vol > .1 and CTV_count1>10: 
        
case.PatientModel.RegionsOfInterest['mover'].CreateAlgebraGeometry(Examination=exami
nation, Algorithm="Auto", ExpressionA={ 'Operation': "Union", 'SourceRoiNames': 
["mover"], 'MarginSettings': { 'Type': "Expand", 'Superior': 0, 'Inferior': 0, 'Anterior': 0, 
'Posterior': 0, 'Right': 0, 'Left': 0 } }, ExpressionB={ 'Operation': "Union", 'SourceRoiNames': 
["External"], 'MarginSettings': { 'Type': "Expand", 'Superior': 0, 'Inferior': 0, 'Anterior': 0, 
'Posterior': 0, 'Right': 0, 'Left': 0 } }, ResultOperation="Subtraction", ResultMarginSettings={ 
'Type': "Expand", 'Superior': 0, 'Inferior': 0, 'Anterior': 0, 'Posterior': 0, 'Right': 0, 'Left': 0 }) 
        try: 
            vol = structure_set.RoiGeometries['mover'].GetRoiVolume() 
            if vol < .002:#for this to trigger: mover is not in CTV, and is in external. in that case, 
if the dose is also super low, we are done with this point 
                check_point = {'x':mover_position[0], 'y':mover_position[1], 
'z':mover_position[2]} 
 
                check_dose_odd = 
plan.TreatmentCourse.TotalDose.InterpolateDoseInPoint(Point=check_point) 
 
                check_dose = math.ceil(check_dose_odd)#this rounds up to the nearest cGy, which 
just makes the math simpler 
 
                if check_dose < 1000: 
                    position = 3 
        except: 
            check_point = {'x':mover_position[0], 'y':mover_position[1], 'z':mover_position[2]} 
 
            check_dose_odd = 
plan.TreatmentCourse.TotalDose.InterpolateDoseInPoint(Point=check_point) 
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            check_dose = math.ceil(check_dose_odd)#this rounds up to the nearest cGy, which 
just makes the math simpler 
 
            if check_dose < 1000: 
                position = 3 
 
 
    return position 
 
 
########################### 
#this script assumes your position is not currently in the compensator or test ROI. It moves 
the mover according to the gantry angle until it reaches the CTV, then continues to move it 
#until it is no longer in the CTV. At that point, it checks the dose, then decides to add to 
addition points the intial point or not 
 
def CTV_in_then_out(case, plan, mover_position, addition_points, beam_set, machine_db, 
examination, dgan_angle, structure_set): 
 
    current_surface_point = mover_position[:] 
    mover_position=move_mover(mover_position, dgan_angle, case, examination) 
    hot_dose = 1 
    CTV_count1 = 0 
    CTV_count2 = 20 
 
    while (CTV_count1<40): 
       position = check_mover_in_CTV(case, plan, mover_position, CTV_count1, 
structure_set)#position =1 if not in CTV, and not in a cold spot in external, position=2 if in 
the ctv, position=3 if not in the ctv, but in external and dose is low 
            
       CTV_count1 = CTV_count1+1 
       if position == 2:  ##this position being 2 means you are now in the CTV, so it sets 
current count to 15 so it stops, then sets the next count to 0 so it can happen 
           CTV_count1 = 40 
           CTV_count2 = 0 
           #await_user_input('We are now in the CTV!')#this can be used to check the script 
        
       if position == 3: #this means that you are in the external and dose is low, so far from 
treatment area 
           CTV_count1 = 20#end this while loop, and don't let the next one start 
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       else:  ##if you are still not in the CTV, you move the mover another step 
           mover_position = move_mover(mover_position, dgan_angle, case, examination) 
     
    while (CTV_count2<20): #this should only happen if you progress to being inside the 
CTV. At this point you move it and continue until outside 
       mover_position = move_mover(mover_position, dgan_angle, case, examination)#you 
want to start by moving it, because the last position was 0 so you might as well start with a 
step 
       position = check_mover_in_CTV(case, plan, mover_position, CTV_count2, 
structure_set) 
       CTV_count2 = CTV_count2+1 
 
       if CTV_count2 == 20: 
           await_user_input("The CTV seems to be unusually thick somewhere and we are stuck. 
Try again.") 
 
       if position == 1: #in this case position =  1 means we are now OUT of the CTV. for this 
if to work, we must have first entered the test roi, then exited the CTV 
           dose_threshold = 4800   
           #await_user_input('We are now checking the dose at this point!')#this can be used to 
check the script   
           hot_dose = point_dose_check(dose_threshold, mover_position, plan, beam_set, 
machine_db) #hot_dose will be 1 if the dose is fine, and 2 if the dose is hot 
 
           CTV_count2 = 20 
                
    return hot_dose 
 
######################## 
#this takes the current center position of mover, then moves it according to gantry 
angle(eventually), then returns the new mover_position list 
def move_mover(mover_position, dgan_angle, case, examination): 
    #dia is the circle diameter 
    dia=.3 
    rgan_angle=dgan_angle*math.pi/180 
         
    mover_position[0] = mover_position[0]-.5*dia*math.sin(rgan_angle) 
    mover_position[1] = mover_position[1] + .5*dia*math.cos(rgan_angle) 
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    case.PatientModel.RegionsOfInterest['mover'].CreateSphereGeometry(Radius=dia, 
Examination=examination, Center={ 'x': mover_position[0], 'y': mover_position[1], 'z': 
mover_position[2] }) 
    return mover_position 
###################### 
 
#this takes the current center position of mover, then moves it according to gantry 
angle(eventually), then returns the new mover_position list 
def move_mover2(mover_point, dgan_angle, case, examination): 
    #dia is the circle diameter 
    dia=.3 
    rgan_angle=dgan_angle*math.pi/180 
         
    mover_point[0] = mover_point[0]-.9*dia*math.sin(rgan_angle) 
    mover_point[1] = mover_point[1] + .9*dia*math.cos(rgan_angle) 
 
    case.PatientModel.RegionsOfInterest['mover2'].CreateSphereGeometry(Radius=dia/2, 
Examination=examination, Center={ 'x': mover_point[0], 'y': mover_point[1], 'z': 
mover_point[2] }) 
    return mover_point 
 
###################### 
#this script is supposed to be used after the cutting one to smooth out the Compensator ROI. 
It contracts it 2 mm, then expands it 2 mm, except in the posterior direction it expands it 
more, then deletes external 
 
def comp_smoother(case, examination): 
 
    with CompositeAction('Expand (Compensator, Image set: CT 1)'): 
 
        
case.PatientModel.RegionsOfInterest['Compensator'].CreateMarginGeometry(Examination=
examination, SourceRoiName="Compensator", MarginSettings={ 'Type': "Expand", 
'Superior': 0.4, 'Inferior': 0.4, 'Anterior': 0.4, 'Posterior': 0.4, 'Right': 0.4, 'Left': 0.4 }) 
 
    with CompositeAction('Contract (Compensator, Image set: CT 1)'): 
 
        
case.PatientModel.RegionsOfInterest['Compensator'].CreateMarginGeometry(Examination=
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examination, SourceRoiName="Compensator", MarginSettings={ 'Type': "Contract", 
'Superior': 0.4, 'Inferior': 0.4, 'Anterior': 0.4, 'Posterior': 0.4, 'Right': 0.4, 'Left': 0.4 }) 
 
    with CompositeAction('ROI Algebra (e_cutout, Image set: CT 1)'): 
 
        
case.PatientModel.RegionsOfInterest['e_cutout'].CreateAlgebraGeometry(Examination=exa
mination, Algorithm="Auto", ExpressionA={ 'Operation': "Union", 'SourceRoiNames': 
["e_cutout"], 'MarginSettings': { 'Type': "Expand", 'Superior': 0, 'Inferior': 0, 'Anterior': 0, 
'Posterior': 0, 'Right': 0, 'Left': 0 } }, ExpressionB={ 'Operation': "Union", 'SourceRoiNames': 
["Compensator"], 'MarginSettings': { 'Type': "Expand", 'Superior': 0, 'Inferior': 0, 'Anterior': 
0, 'Posterior': 0, 'Right': 0, 'Left': 0 } }, ResultOperation="Subtraction", 
ResultMarginSettings={ 'Type': "Expand", 'Superior': 0, 'Inferior': 0, 'Anterior': 0, 'Posterior': 
0, 'Right': 0, 'Left': 0 }) 
 
###################### 
#this sub script takes the list of points on the surface of vtest and subtracts the addition points 
from them 
def COMP_cutter(case, addition_points, subtraction_points): 
    addwords = str(addition_points) 
    subwords = str(subtraction_points) 
    await_user_input(addwords)#this can be sued to check the script 
    await_user_input(subwords)#this can be used to check the script 
    q=len(addition_points) 
    if q>0: 
        for n in range(0,q): 
            with CompositeAction('Create Sphere ROI (addition)'): 
 
                
case.PatientModel.RegionsOfInterest['addition'].CreateSphereGeometry(Radius=.25, 
Examination=examination, Center={ 'x': addition_points[n][0], 'y': addition_points[n][1], 'z': 
addition_points[n][2] }) 
 
            with CompositeAction('ROI Algebra (Compensator)'): 
 
                
case.PatientModel.RegionsOfInterest['Compensator'].CreateAlgebraGeometry(Examination=
examination, Algorithm="Auto", ExpressionA={ 'Operation': "Union", 'SourceRoiNames': 
["Compensator"], 'MarginSettings': { 'Type': "Expand", 'Superior': 0, 'Inferior': 0, 'Anterior': 
0, 'Posterior': 0, 'Right': 0, 'Left': 0 } }, ExpressionB={ 'Operation': "Union", 
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'SourceRoiNames': ["addition"], 'MarginSettings': { 'Type': "Expand", 'Superior': 0, 'Inferior': 
0, 'Anterior': 0, 'Posterior': 0, 'Right': 0, 'Left': 0 } }, ResultOperation="Union", 
ResultMarginSettings={ 'Type': "Expand", 'Superior': 0, 'Inferior': 0, 'Anterior': 0, 'Posterior': 
0, 'Right': 0, 'Left': 0 }) 
 
    gg=len(addition_points) 
    if gg>0: 
        for n in range(0,gg): 
            with CompositeAction('Create Sphere ROI (subtraction)'): 
 
                
case.PatientModel.RegionsOfInterest['subtraction'].CreateSphereGeometry(Radius=.15, 
Examination=examination, Center={ 'x': subtraction_points[n][0], 'y': 
subtraction_points[n][1], 'z': subtraction_points[n][2] }) 
 
            with CompositeAction('ROI Algebra (Compensator)'): 
 
                
case.PatientModel.RegionsOfInterest['Compensator'].CreateAlgebraGeometry(Examination=
examination, Algorithm="Auto", ExpressionA={ 'Operation': "Union", 'SourceRoiNames': 
["Compensator"], 'MarginSettings': { 'Type': "Expand", 'Superior': 0, 'Inferior': 0, 'Anterior': 
0, 'Posterior': 0, 'Right': 0, 'Left': 0 } }, ExpressionB={ 'Operation': "Union", 
'SourceRoiNames': ["subtraction"], 'MarginSettings': { 'Type': "Expand", 'Superior': 0, 
'Inferior': 0, 'Anterior': 0, 'Posterior': 0, 'Right': 0, 'Left': 0 } }, 
ResultOperation="Subtraction", ResultMarginSettings={ 'Type': "Expand", 'Superior': 0, 
'Inferior': 0, 'Anterior': 0, 'Posterior': 0, 'Right': 0, 'Left': 0 }) 
 
################### 
#this script will check the dose at a point, then return with a response of whether the dose is 
too high, too low, or normal 
def point_dose_check(dose_threshold, mover_position, plan, beam_set, machine_db): 
    dose_condition=1  #dose condition 1 means the dose is satisfactory, and dose condition 2 
means the dose is too hot,dose condition 3 means too cold 
     
    check_point = {'x':mover_position[0], 'y':mover_position[1], 'z':mover_position[2]} 
 
    check_dose_odd = 
plan.TreatmentCourse.TotalDose.InterpolateDoseInPoint(Point=check_point) 
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    check_dose = math.ceil(check_dose_odd)#this rounds up to the nearest cGy, which just 
makes the math simpler 
 
    if check_dose >= dose_threshold: 
        dose_condition = 2 
 
    if check_dose <4000: 
        dose_condition = 3 
 
    return dose_condition 
 
################### 
#this script will create a list of points that are the starting check points in the xy plane, based 
on the gantry angle, isocenter, and applicator size 
def start_points_finder(beam_set, dgan_angle): 
    #first start off creating all the variables I will need 
    dia = .3 
    start_points=[] 
    rgan_angle=dgan_angle*math.pi/180 
    xshift = dia*math.cos(rgan_angle) 
    yshift = dia*math.sin(rgan_angle) 
    app_size = beam_set.Beams['electron beam'].Applicator.DicomApplicatorId 
    spot = beam_set.Beams['electron beam'].Isocenter.Position 
    iso_x = spot.x+7*math.sin(rgan_angle)#this moves the starting postition above the 
compensator 
    iso_y = spot.y-7*math.cos(rgan_angle) 
    iso_z = spot.z 
    iso_to_edge = 11 
 
    startx=iso_x-iso_to_edge*math.cos(rgan_angle) 
    starty=iso_y-iso_to_edge*math.sin(rgan_angle) 
    startz=iso_z+iso_to_edge 
 
    steps = int(math.floor(2*iso_to_edge/dia)) 
    wordyword = str(steps) 
    #await_user_input(wordyword) #this can be uncommented to check the step number 
    #these nested for loops create a list of all the starting check points 
    for n in range(0, steps): 
        for k in range(0, steps): 
            xpoint = startx + k*xshift 
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            ypoint = starty + k*yshift 
            zpoint = startz - n*dia 
            new_point = [xpoint, ypoint, zpoint] 
            start_points.append(new_point) 
            #await_user_input('I added a point!') #this can be uncommented just to check its 
running 
 
    return start_points 
 
################### 
#this script finds which starting points actually go into the e_cutout and not compensator 
def time_waster_points(mover_point, start_points, start_num1, dgan_angle, case, 
examination): 
    #before we start checking points, we have to see which of the start points we really want to 
check. uninteresting start points will be added to the time wasters list 
    ##need to find a better way to exclude these for the comp in air. Probably just check if it 
touches the insert within 5 steps and if it does we cut it 
    time_wasters = [] 
    for n in range(0, start_num1): 
 
        mover_point[0] = start_points[n][0]#at the beginning of every start point loop 
reinitialize the starting mover position 
        mover_point[1] = start_points[n][1] 
        mover_point[2] = start_points[n][2] 
        counter = 0 
        check = 3 
 
        while (check==3): 
            comp_pos_check = check_mover2_in_comp(case, plan) 
            mover_point = move_mover2(mover_point, dgan_angle, case, examination) 
            counter = counter+1 
         
            if counter>15: 
                check = 1 
                time_wasters.insert(0, n)#this means this point moved 15 times without 
intersecting the compensator, so its not a valuable line to me 
                ##also, by inserting each indice at the beginning of the list I make sure the list is in 
decending order, which makes the later indices valid once I start deleting later 
            if comp_pos_check == 1: 
                check = 1 
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    return time_wasters 
 
################### 
def mover_point_mover(mover_point, dgan_angle): 
    #dia is the circle diameter 
    dia=.3 
    rgan_angle=dgan_angle*math.pi/180 
         
    mover_point[0] = mover_point[0]-.9*dia*math.sin(rgan_angle) 
    mover_point[1] = mover_point[1] + .9*dia*math.cos(rgan_angle) 
 
    return mover_point 
 
################### 
#this function will check the dose at the mover point, then return a value that says if it is high 
or not 
def mover_point_dose_check(mover_point, case, examination): 
    dose_threshold = 4000 
    dose_condition = 1#1 means that the doses are all low 
    check_point = {'x':mover_point[0], 'y':mover_point[1], 'z':mover_point[2]} 
 
    check_dose_odd = 
plan.TreatmentCourse.TotalDose.InterpolateDoseInPoint(Point=check_point) 
 
    check_dose = math.ceil(check_dose_odd)#this rounds up to the nearest cGy, which just 
makes the math simpler 
 
    if check_dose >= dose_threshold: 
        dose_condition = 2#this means dose is high 
 
    return dose_condition 
 
###################### 
#this is where the script really starts 
 
#start off by getting the plan info 
plan1 = get_current("Plan") 
set_check = plan1.GetStructureSet() 
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#second, check and see if there already is a compensator ROI in place 
try: 
    comp_check = set_check.RoiGeometries["Compensator"].GetCenterOfRoi() 
except:#if there is not a compensator ROI, then initialize it 
    comp_init()  #start it off!   
 
await_user_input("This is the last stop before it takes a (really) long time. Look at the dose 
distribution and see if you would like to alter the Compensator shape now. If you change it, 
make sure to recalculate dose before proceeding.") 
 
#third, get all the beam and case info 
beam_set = get_current("BeamSet") 
case=get_current("Case") 
examination = get_current("Examination") 
plan = get_current("Plan") 
machine_db=get_current("MachineDB") 
 
#fourth, set up all the data sets I will need 
mover_position = [0,0,0]#start it empty 
dgan_angle=beam_set.Beams['electron beam'].GantryAngle#get the gantry angle to start off 
with 
addition_points=[]#create the list that will store points to be used to cut up the compensator 
subtraction_points=[]#create the list that will store points to cut from the compensator 
dose_threshold = 4600 #this can be adjusted depending on how sensitive you want the 
algorithm to be. 
start_points = start_points_finder(beam_set, dgan_angle)#creates a list of origin (x,y,z) 
points for the ray lines 
start_num1 = len(start_points) 
mover_point = [0,0,0] 
create_mover(mover_position, case)#here we create the mover and addition rois that we will 
fill and use later 
time_wasters = time_waster_points(mover_point, start_points, start_num1, dgan_angle, case, 
examination) 
counter=0#for now this is used to determine the edge of the CTV 
check=3#this is the while loop check condition 
structure_set=plan.GetStructureSet() 
 
##now we delete all the start points that don't go into the compensator 
tw_len = len(time_wasters) 
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for n in range(0,tw_len): 
    start_points.pop(time_wasters[n]) 
 
start_num = len(start_points) 
 
#this section can be used to determine if the script is working to take out the wasted points 
#words = str(start_num1) 
#words2 = str(tw_len) 
#words3 = str(start_num) 
#await_user_input(words) 
#await_user_input(words2) 
#await_user_input(words3) 
 
#this for loop is the one that goes and checks all the remaining start points, then adds the 
points that need to be modified to a list 
for n in range(0, start_num): ##now in these for loops we are checking the points that were 
left over that have high doses 
    counter=0#makes sure we don't go too far from any one start point 
    check=3#this is the while loop check condition 
    mover_position[0] = start_points[n][0]#at the beginning of every start point loop 
reinitialize the starting mover position 
    mover_position[1] = start_points[n][1] 
    mover_position[2] = start_points[n][2] 
 
    while (check==3): 
 
        mover_position = move_mover(mover_position, dgan_angle, case, examination)#starts 
off by moving the move rroi to the next position 
        counter=counter+1#increase the counter each iteration 
        if counter>35:#if we have had 25 steps and no interaction with a relevent ROI we call it 
quits 
            check=1 
 
        position = check_mover_in_Compensator(case, plan)#now that the ROI is moved, we 
see if it is in the ROI we care about 
        if position == 1:  #if it is in the relevent ROI(Compensator), we restart the search and 
look for it to leave the CTV 
            #this takes over at surface of compensator, goes to distal edge of CTV, checks dose, 
then adds point to addition points if necessary 
            current_surface_point = copy.deepcopy(mover_position) 
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            #await_user_input('We are at the surface of the compensator right here')#can be used 
to check the script is working 
             
            dose_check_condition = CTV_in_then_out(case, plan, mover_position, 
addition_points, beam_set, machine_db, examination, dgan_angle, structure_set) 
            #lotswords = str(dose_check_condition)#this and the following can be used to check 
the script 
            #await_user_input(lotswords) 
            if dose_check_condition == 2: 
                addition_points.append([current_surface_point[0], current_surface_point[1], 
current_surface_point[2]]) 
            if dose_check_condition == 3: 
                subtraction_points.append([current_surface_point[0], current_surface_point[1], 
current_surface_point[2]]) 
                             
            counter = 0#and we reset the counter 
            check = 1#and we end the while loop, which steps us forward in the for loop to our 
next start point 
 
#now we modify the compensator based on the points found above 
COMP_cutter(case, addition_points, subtraction_points) 
 
#now we smooth out the bumps we created in the compensator 
comp_smoother(case, examination) 
 
#after adjusting the compensator, delete mover and addition so they don't interfere with a 
subsequent run 
with CompositeAction('Delete ROI (mover, addition)'): 
 
  case.PatientModel.RegionsOfInterest['mover'].DeleteRoi() 
  case.PatientModel.RegionsOfInterest['addition'].DeleteRoi() 
  case.PatientModel.RegionsOfInterest['mover2'].DeleteRoi() 
  case.PatientModel.RegionsOfInterest['subtraction'].DeleteRoi() 
 
  # CompositeAction ends  
 
#and last but not least, dose recalc 
beam_set.ComputeDose(ComputeBeamDoses=True, 
DoseAlgorithm="ElectronMonteCarlo", ForceRecompute=False)  
160 
 
Bibliography 
1 R.L. Siegel, K.D. Miller, A. Jemal, "Cancer statistics, 2018," CA: a cancer journal for 
clinicians 68, 7-30 (2018). 
2 P. McGale, C. Taylor, C. Correa, D. Cutter, F. Duane, M. Ewertz, R. Gray, G. 
Mannu, R. Peto, T. Whelan, Y. Wang, Z. Wang, S. Darby, EBCTCG, "Effect of 
radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year 
breast cancer mortality: meta-analysis of individual patient data for 8135 women in 
22 randomised trials," The Lancet 383, 2127-2135 (2014). 
3 B. Fisher, S. Anderson, J. Bryant, R.G. Margolese, M. Deutsch, E.R. Fisher, J.H. 
Jeong, N. Wolmark, "Twenty-year follow-up of a randomized trial comparing total 
mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of 
invasive breast cancer," N Engl J Med 347, 1223-1241 (2002). 
4 U. Veronesi, N. Cascinelli, L. Mariani, M. Greco, R. Saccozzi, A. Luini, M. Aguilar, 
E. Marubini, "Twenty-year follow-up of a randomized study comparing breast-
conserving surgery with radical mastecomy for early breast cancer," N Engl J Med 
347, 1227-1232 (2002). 
5 M. Clarke, R. Collins, S. Darby, "Early Breast Cancer Trialists' Collaborative Group 
(EBCTCG). Effects of radiotherapy and of differences in the extent of surgery for 
early breast cancer on local recurrence and 15-year survival: an overview of 
randomized trials," Lancet 366, 2087-2106 (2005). 
6 L.J. Pierce, J.B. Butler, M.K. Martel, D.P. Normolle, T. Koelling, R.B. Marsh, A.S. 
Lichter, B.A. Fraass, "Postmastectomy radiotherapy of the chest wall: Dosimetric 
161 
 
comparison of common techniques," International journal of radiation oncology, 
biology, physics 52, 1220-1230 (2002). 
7 J. Ma, J. Li, J. Xie, J. Chen, C. Zhu, G. Cai, Z. Zhang, X. Guo, J. Chen, "Post 
mastectomy linac IMRT irradiation of chest wall and regional nodes: dosimetry data 
and acute toxicities," Radiation Oncology 82013). 
8 D.A. Low, G. Starkschall, S.W. Bujnowski, L.L. Wang, K.R. Hogstrom, "Electron 
bolus design for radiotherapy treatment planning: Bolus design algorithms," Medical 
Physics 19, 115-125 (1991). 
9 D.A. Low, G. Starkschall, N.E. Sherman, S.W. Bujnowski, J.R. Ewton, K.R. 
Hogstrom, "Computer-aided design and fabrication of an electron bolus for treatment 
of the paraspinal muscles," International journal of radiation oncology, biology, 
physics 33, 1127-1138 (1995). 
10 M.M. Kim, R.J. Kudchadker, J.E. Kanke, S. Zhang, G.H. Perkins, "Bolus electron 
conformal therapy for the treatment of recurrent inflammatory breast cancer: a case 
report," Medical dosimetry : official journal of the American Association of Medical 
Dosimetrists 37, 208-213 (2012). 
11 G.H. Perkins, M.D. McNeese, J.A. Antolak, T.A. Buchholz, E.A. Strom, K.R. 
Hogstrom, "A custom three-dimensional electron bolus technique for optimization of 
postmastectomy irradiation," International journal of radiation oncology, biology, 
physics 51, 1142-1151 (2001). 
12 D. Opp, K. Forster, W. Li, G. Zhang, E.E. Harris, "Evaluation of bolus electron 
conformal therapy compared with conventional techniques for the treatment of left 
chest wall postmastectomy in patients with breast cancer," Medical dosimetry : 
162 
 
official journal of the American Association of Medical Dosimetrists 38, 448-453 
(2013). 
13 R.J. Kudchadker, K.R. Hogstrom, A.S. Garden, M.D. McNeese, R.A. Boyd, J.A. 
Antolak, "Electron conformal radiotherapy using bolus and intensity modulation," 
International journal of radiation oncology, biology, physics 53, 1023-1037 (2002). 
14 R.J. Kudchadker, J.A. Antolak, W.H. Morrison, P.F. Wong, K.R. Hogstrom, 
"Utilization of custom electron bolus in head and neck radiotherapy," Journal of 
Applied Clinical Medical Physics 4, 321-333 (2003). 
15 O.A. Zeidan, B.D. Chauhan, W.W. Estabrook, T.R. Willoughby, R.R. Manon, S.L. 
Meeks, "Image-guided bolus electron conformal therapy-a case study," Journal of 
applied clinical medical physics / American College of Medical Physics 12, 68-75 
(2010). 
16 J. Lin, M.H. Lin, A. Hall, B. Zhang, D. Singh, W.F. Regine, "Comparison of bolus 
electron conformal therapy plans to traditional electron and proton therapy to treat 
melanoma in the medial canthus," Practical radiation oncology 6, 105-109 (2016). 
17 L. Hong, K.M. Alektiar, M. Hunt, E. Venkatraman, S.A. Leibel, "Intensity-modulated 
radiotherapy for soft tissue sarcoma of the thigh," International journal of radiation 
oncology, biology, physics 59, 752-759 (2004). 
18 J.M. Galvin, G.J. D'Angio, G. Walsh, "Use of Tissue Compensators to Improve the 
Dose Uniformity for Total-Body Irradiation," International journal of radiation 
oncology, biology, physics 6, 767-771 (1980). 
19 P.C. Williams, "IMRT: delivery techniques and quality assurance," The British 
journal of radiology 76, 766-776 (2003). 
163 
 
20 S. Su, K. Moran, J.L. Robar, "Design and production of 3D printed bolus for electron 
radiation therapy," Journal of Applied Clinical Medical Physics 15, 194-211 (2014). 
21 C. Barnatt, 3D Printing: The Next Industrial Revolution, Second ed. (Explaining The 
Future, 2014). 
22 S.G. Ju, M.K. Kim, C.S. Hong, J.S. Kim, Y. Han, D.H. Choi, D. Shin, S.B. Lee, 
"New technique for developing a proton range compensator with use of a 3-
dimensional printer," International journal of radiation oncology, biology, physics 88, 
453-458 (2014). 
23 W. Zou, T. Fisher, M. Zhang, L. Kim, T. Chen, V. Narra, B. Swann, R. Singh, R. 
Siderit, L. Yin, B.K. Teo, M. Mckenna, J. McDonough, Y.J. Ning, "Potential of 3D 
printing technologies for fabrication of electron bolus and proton compensators," 
Journal of Applied Clinical Medical Physics 16, 90-98 (2015). 
24 S. Burleson, J. Baker, A.T. Hsia, Z. Xu, "Use of 3D printers to create a patient-
specific 3D bolus for external beam therapy," Journal of Applied Clinical Medical 
Physics 16, 166-178 (2015). 
25 A. Marro, T. Bandukwala, W. Mak, "Three-Dimensional Printing and Medical 
Imaging: A Review of the Methods and Applications," Current problems in 
diagnostic radiology 45, 2-9 (2016). 
26 M.F. Bieniosek, B.J. Lee, C.S. Levin, "Technical Note: Characterization of custom 
3D printed multimodality imaging phantoms," Med Phys 42, 5913-5918 (2015). 
27 E.D. Ehler, B.M. Barney, P.D. Higgins, K.E. Dusenbery, "Patient specific 3D printed 
phantom for IMRT quality assurance," Physics in medicine and biology 59, 5763-
5773 (2014). 
164 
 
28 J.I. Gear, C. Long, D. Rushforth, S.J. Chittenden, C. Cummings, G.D. Flux, 
"Development of patient-specific molecular imaging phantoms using a 3D printer," 
Medical Physics 41, 082502 (2014). 
29 K. Nattagh, T. Siauw, J. Pouliot, I.C. Hsu, J.A. Cunha, "A training phantom for 
ultrasound-guided needle insertion and suturing," Brachytherapy 13, 413-419 (2014). 
30 J.I. Gear, C. Cummings, A.J. Craig, A. Divoli, C.D. Long, M. Tapner, G.D. Flux, 
"Abdo-Man: a 3D-printed anthropomorphic phantom for validating quantitative 
SIRT," EJNMMI physics 3, 17 (2016). 
31 J. Madamesila, P. McGeachy, J.E. Villarreal Barajas, R. Khan, "Characterizing 3D 
printing in the fabrication of variable density phantoms for quality assurance of 
radiotherapy," Physica Medica 32, 242-247 (2016). 
32 R. Zavan, P. McGeachy, J. Madamesila, J.E. Villarreal-Barajas, R. Khan, 
"Verification of Acuros XB dose algorithm using 3D printed low-density phantoms 
for clinical photon beams," Journal of applied clinical medical physics / American 
College of Medical Physics2018). 
33 Y. Zhao, K. Moran, M. Yewondwossen, J. Allan, S. Clarke, M. Rajaraman, D. Wilke, 
P. Joseph, J.L. Robar, "Clinical applications of 3-dimensional printing in radiation 
therapy," Medical dosimetry : official journal of the American Association of 
Medical Dosimetrists 42, 150-155 (2017). 
34 M. Lukowiak, K. Jezierska, M. Boehlke, M. Wiecko, A. Lukowiak, W. Podraza, M. 
Lewocki, B. Masojc, M. Falco, "Utilization of a 3D printer to fabricate boluses used 
for electron therapy of skin lesions of the eye canthi," Journal of applied clinical 
medical physics 18, 76-81 (2017). 
165 
 
35 J.W. Park, J.W. Yea, "Three-dimensional customized bolus for intensity-modulated 
radiotherapy in a patient with Kimura's disease involving the auricle," Cancer 
radiotherapie : journal de la Societe francaise de radiotherapie oncologique 20, 205-
209 (2016). 
36 R.A. Canters, I.M. Lips, M. Wendling, M. Kusters, M. van Zeeland, R.M. Gerritsen, 
P. Poortmans, C.G. Verhoef, "Clinical implementation of 3D printing in the 
construction of patient specific bolus for electron beam radiotherapy for non-
melanoma skin cancer," Radiotherapy and oncology : journal of the European Society 
for Therapeutic Radiology and Oncology 121, 148-153 (2016). 
37 R. Sethi, A. Cunha, K. Mellis, T. Siauw, C. Diederich, J. Pouliot, I.C. Hsu, "Clinical 
applications of custom-made vaginal cylinders constructed using three-dimensional 
printing technology," Journal of contemporary brachytherapy 8, 208-214 (2016). 
38 W.K. Choi, J.C. Chun, S.G. Ju, B.J. Min, S.Y. Park, H.R. Nam, C.-S. Hong, M. Kim, 
B.Y. Koo, D.H. Lim, "Efficacy and Accuracy of Patient Specific Customize Bolus 
Using a 3-Dimensional Printer for Electron Beam Therapy," Progress in Medical 
Physics 27, 64 (2016). 
39 J.W. Park, S.A. Oh, J.W. Yea, M. Kang, K, "Fabrication of malleable three-
dimensional-printed customized bolus using three-dimensional scanner," PLoS ONE 
12, 9 (2017). 
40 S.G. Ju, M.K. Kim, C.S. Hong, J.S. Kim, Y. Han, D.H. Choi, D. Shin, S.B. Lee, 
"New technique for developing a proton range compensator with use of a 3-
dimensional printer," Int J Radiat Oncol Biol Phys 88, 453-458 (2014). 
166 
 
41 J.I. Gear, C. Long, D. Rushforth, S.J. Chittenden, C. Cummings, G.D. Flux, 
"Development of patient-specific molecular imaging phantoms using a 3D printer," 
Medical physics 41, 082502 (2014). 
42 M. Leary, T. Kron, C. Keller, R. Franich, P. Lonski, A. Subic, M. Brandt, "Additive 
manufacture of custom radiation dosimetry phantoms: An automated method 
compatible with commercial polymer 3D printers," Materials & Design 86, 487-499 
(2015). 
43 D.F. Craft, R.M. Howell, "Preparation and Fabrication of a Full-scale, Sagittal-sliced, 
3D-printed, Patient-specific Radiotherapy Phantom " Journal of Applied Clinical 
Medical Physics 18, 285-292 (2017). 
44 J.A.M. Cunha, K. Mellis, R. Sethi, T. Siauw, A. Sudhyadhom, A. Garg, K. Goldberg, 
I. Hsu, J. Pouliot, "Evaluation of PC-ISO for customized, 3D printed, gynecologic 
192-Ir HDR brachytherapy applicators," Journal of Applied Clinical Medical Physics 
16, 246-253 (2014). 
45 O.L. Dancewicz, S.R. Sylvander, T.S. Markwell, S.B. Crowe, J.V. Trapp, 
"Radiological properties of 3D printed materials in kilovoltage and megavoltage 
photon beams," Phys Med 38, 111-118 (2017). 
46 F.M. Khan, K.P. Doppke, K.R. Hogstrom, G.J. Kutcher, R. Nath, S.C. Prasad, J.A. 
Purdy, M. Rozenfeld, B.L. Werner, "Clinical electron-beam dosimetry: Report of 
AAPM Radiation Therapy Committee Task Group No. 25," Medical Physics 18, 73-
109 (1991). 
47 M.J. Berger, J.S. Coursey, M.A. Zucker, J. Chang, "ESTAR, PSTAR, and ASTAR: 
Computer Programs for Calculating Stopping-Power and Range Tables for Electrons, 
167 
 
Protons, and Helium Ions (version 1.2.3),"  (National Institute of Standards and 
Technology, Gaithersburg, MD, http://physics.nist.gov/Star, 2005). 
48 R. Ger, E.A. Burgett, R.R. Price, D.F. Craft, S.F. Kry, R.M. Howell, "WE-D-BRA-
05: Pseudo In Vivo Patient Dosimetry Using a 3D-Printed Patient-Specific Phantom," 
Medical Physics 42, 3667-3667 (2015). 
49 E. Radecka, M. Brehmer, K. Holmgren, G. Palm, P. Magnusson, A. Magnusson, 
"Pelvicaliceal biomodeling as an aid to achieving optimal access in percutaneous 
nephrolithotripsy," Journal of Endourology 20, 92-101 (2006). 
50 R.A. Watson, "A low-cost surgical application of additive fabrication," Journal of 
Surgical Education 71, 14-17 (2014). 
51 V. Waran, V. Narayanan, R. Karuppiah, D. Pancharatnam, H. Chandran, R. Raman, 
Z.A. Rahman, S.L. Owen, T.Z. Aziz, "Injecting realism in surgical training-initial 
simulation experience with custom 3D models," Journal of Surgical Education 71, 
193-197 (2014). 
52 D.F. Craft, S.F. Kry, P. Balter, M. Salehpour, W. Woodward, R.M. Howell, "Material 
Matters: Analysis of Density Uncertainty in 3D Printing and its Consequences for 
Radiation Oncology," Medical Physics 45, 1614-1621 (2018). 
53 R.A. Canters, I.M. Lips, M. Wendling, M. Kusters, M. van Zeeland, R.M. Gerritsen, 
P. Poortmans, C.G. Verhoef, "Clinical implementation of 3D printing in the 
construction of patient specific bolus for electron beam radiotherapy for non-
melanoma skin cancer," Radiotherapy and oncology : journal of the European Society 
for Therapeutic Radiology and Oncology2016). 
168 
 
54 G.S. Ibbott, D.S. Followill, H.A. Molineu, J.R. Lowenstein, P.E. Alvarez, J.E. Roll, 
"Challenges in credentialing institutions and participants in advanced technology 
multi-institutional clinical trials," Int J Radiat Oncol Biol Phys 71, S71-75 (2008). 
55 A. Molineu, N. Hernandez, T. Nguyen, G. Ibbott, D. Followill, "Credentialing results 
from IMRT irradiations of an anthropomorphic head and neck phantom," Med Phys 
40, 022101 (2013). 
56 S.X. Chang, T.J. Cullip, K.M. Deschesne, E.P. Miller, J.G. Rosenman, 
"Compensators: An alternative IMRT delivery technique," Journal of Applied 
Clinical Medical Physics 5, 15-36 (2004). 
57 T. Kataria, K. Sharma, V. Subramani, K.P. Karrthick, S.S. Bisht, "Homogeneity 
Index: An objective tool for assessment of conformal radiation treatments," J Med 
Phys 37, 207-213 (2012). 
58 T.H. Kirby, W.F. Hanson, D.A. Johnston, "Uncertainty analysis of absorbed dose 
calculations from thermoluminescence dosimeters," Medical Physics 19, 1427-1433 
(1992). 
59 J.Y. Huang, D.S. Followill, X.A. Wang, S.F. Kry, "Accuracy and sources of error of 
out-of field dose calculations by a commercial treatment planning system for 
intensity-modulated radiation therapy treatments," Journal of applied clinical medical 
physics / American College of Medical Physics 14, 186-197 (2013). 
60 R.M. Howell, S.B. Scarboro, P.J. Taddei, S. Krishnan, S.F. Kry, W.D. Newhouser, 
"Methodology for determining doses to in-field, out-of-field and partially in-field 
organs for late effects studies in photon radiotherapy," Physics in medicine and 
biology 55, 7009-7023 (2010). 
169 
 
61 S. Diamantopoulos, I. Kantemiris, G. Patatoukas, M. Dilvoi, E. Efstathopoulos, V. 
Kouloulias, K. Platoni, "Theoretical and experimental determination of scaling 
factors in electron dosimetry for 3D-printed polylactic acid," Med Phys2018). 
62 B.L. Cox, K.D. Ludwig, E.B. Adamson, K.W. Eliceiri, S.B. Fain, "An open source, 
3D printed preclinical MRI phantom for repeated measures of contrast agents and 
reference standards," Biomedical physics & engineering express 42018). 
63 R. Rai, D. Manton, M.G. Jameson, S. Josan, M.B. Barton, L.C. Holloway, G.P. 
Liney, "3D printed phantoms mimicking cortical bone for the assessmennt of 
untrashort echo time magnetic resonance imaging," Medical Physics 45, 758-766 
(2017). 
64 C. Hazelaar, M.V. Eijnatten, M. Dahele, J. Wolff, T. Forouzanfar, B. Slotman, 
W.F.A.R. Verbakel, "Using 3D printing techniques to create an anthropomorphic 
thorax phantom for medical imaging purposes," Medical Physics 45, 92-100 (2017). 
65 M. Peters, D.F. Craft, G. Baltz, D.S. Followill, R.M. Howell, "SU-E-108-02: Dual-
Material 3D Printing of An Anthropomorphic Head Phantom," Medical Physics 44, 
2725 (2017). 
66 D.F. Craft, E.A. Burgett, R.M. Howell, "EP-1435: Evaluation of single material and 
multimaterial patient-specific, 3D-printed radiotherapy phantoms," Radiotherapy and 
Oncology 123, S765-S766 (2016). 
67 D.F. Craft, M. Peters, G. Baltz, R.M. Howell, "SU-I-GPD-T-218: Comparison of 
Single and Dual Material 3D Printed Patient-Specific Radiotherapy Phantoms," 
Medical Physics 44, 2877 (2017). 
170 
 
68 M.L. Yap, M. Tieu, J. Sappiatzer, T. Panzarella, J. Cuartero, D. McCready, A. Fyles, 
"Outcomes in Patients Treated with Post-mastectomy Chest Wall Radiotherapy 
without the Routine Use of Bolus," Clin Oncol (R Coll Radiol)2018). 
69 L. Drost, N. Li, D. Vesprini, A. Sangha, J. Lee, E. Leung, E. Rakovitch, C. Yee, E. 
Chow, M. Ruschin, "Prospective Study of Breast Radiation Dermatitis," Clinical 
breast cancer2018). 
70 A. Parekh, A.D. Dholakia, D.J. Zabranksy, F. Asrari, M. Camp, M. Habibi, R. 
Zellars, J.L. Wright, "Predictors of radiation-induced acute skin toxicity in breast 
cancer at a single institution: Role of fractionation and treatment volume," Advances 
in radiation oncology 3, 8-15 (2018). 
71 F.N. Bray, B.J. Simmons, A.H. Wolfson, K. Nouri, "Acute and Chronic Cutaneous 
Reactions to Ionizing Radiation Therapy," Dermatology and therapy 6, 185-206 
(2016). 
72 S.M. Bentzen, M. Overgaard, "Relationship between early and late normal-tissue 
injury after postmastectomy radiotherapy," Radiotherapy and Oncology 20, 159-165 
(1991). 
73 G. Baltz, P. Chi, D.F. Craft, M. Peters, J. Pollard, R.M. Howell, "SU-I-GPD-T-513: 
Use and Validation of Contoured 3D-Printed Neck Compensators for Total Body 
Irradiation," Medical Physics 44, 2947 (2017). 
74 H.E. Johns, J.R. Cunningham, The Physics of Radiology, 4th ed. (Charles C. Thomas, 
Springfield, IL, 1983). 
 
  
171 
 
Vita 
Daniel Fowler Craft was born in Phoenix, Arizona on February 16, 1989, the son of Patricia 
Fowler Craft and Richard Wayne Craft Sr. After completing his work at Centennial High 
School, Gresham, Oregon in 2007, he entered Brigham Young University in Provo, Utah. He 
received the degree of Bachelor of Science with a major in applied physics from Brigham 
Young University in April, 2013. In August of 2013 he entered The University of Texas MD 
Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences. 
 
Permanent address: 
 
11923 SE Wiese Rd.  
Damascus, Oregon, 97089 
